All articles tagged: Immunology
Medical xPress
20 November at 03.11 PM
Bayesian metamodeling provides insight into how T cells are activatedA research team behind a new study at the Hebrew University of Jerusalem has made an important breakthrough in understanding how immune cells known as T cells are activated. |
Medical xPress
20 November at 02.37 PM
Scientists find a region of mouse gut tightly regulated by the immune systemThe intestine maintains a delicate balance in the body, absorbing nutrients and water while maintaining a healthy relationship with the gut microbiome, but this equilibrium is disrupted in parts of the intestine in conditions such as celiac disease, ulcerative colitis, and Crohn's disease. Scientists don't fully understand how different regions of the organ resist or adapt to changes in the enviro |
Medical xPress
20 November at 11.00 AM
Map of human thymus sheds light on how immune responses are built and maintained at early lifeBy creating the first spatial atlas of the developing human thymus, a vital organ that trains immune cells to protect against infections and cancer, scientists have discovered that the foundation for lifelong immunity is established earlier than previously thought. |
Medical xPress
20 November at 11.00 AM
Preventing severe malaria by harnessing natural human antibodiesMalaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year—most of them African children under five. |
Medical xPress
19 November at 03.32 PM
Developing an antibody to combat age-related muscle atrophyWe all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years. For example, the decrease of muscle mass and function, leading to weakness and atrophy. This is a pressing concern in a super-aging society like Japan where—while people live longer—without proper muscle streng |
Medical xPress
15 November at 12.08 PM
In vitro model enables study of age-specific responses to COVID mRNA vaccinesmRNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, Ph.D., and Ofer Levy, MD, Ph.D., have found some answers, while providing proof-of-concept of a new system that can model vaccine responses in a dish. |
Medical xPress
14 November at 11.10 AM
The power of human milk for infant healthTwo open-access reviews by a renowned neonatal immunologist have highlighted the uniqueness of the developing infant immune system and how human milk provides a personalized and real-time approach to meeting the ever-changing needs of newborns. |
Medical xPress
13 November at 12.35 PM
Skull bone marrow expands throughout life and remains healthy during aging, researchers discoverThe ability of the bone marrow to produce healthy blood cells declines significantly with age, leading to age-related inflammation and disease. A team of researchers at the Max Planck Institute for Molecular Biomedicine in Münster, Germany, has shown that the skull bone marrow is an exception to bone marrow aging and actually increases blood production throughout life. Specialized blood vessels wi |
Medical xPress
13 November at 08.58 AM
AI analysis of PET/CT images predicts side effects of immunotherapy in lung cancerDr. Watanabe and his team from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious side effect of immunotherapy in lung cancer. The study is published in the journal Academic Radiology. |
Medical xPress
12 November at 04.20 PM
Lab-grown human immune system uncovers weakened response in cancer patientsTo better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny lab-grown models of human immune systems. |
Medical xPress
12 November at 03.09 PM
Goblet cells could be the guardians of the gutIn a recent study, researchers at the University of California, San Diego, have provided new insights into the central role of goblet cells—specialized cells that line the gut—in maintaining a healthy and balanced immune environment within the gastrointestinal (GI) tract. |
Medical xPress
08 November at 07.40 AM
Increased psoriasis risk found in cancer patients treated with immune checkpoint inhibitorsResearchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI) treatments, with implications for other immune-related adverse events. |
Medical xPress
07 November at 11.30 AM
Immunoglobulin levels found to escalate with age in both male and female miceA large interdisciplinary team of researchers has found that as mice age, levels of a certain type of immunoglobulin escalate, exacerbating tissue aging. In their paper published in the journal Cell, the group describes how they analyzed tissue from multiple mouse organs at different ages, looking specifically at senescence-sensitive spots, and what they learned by doing so. |
Medical xPress
06 November at 01.07 PM
Bioengineers shed light on dosing challenges for cancer immunotherapyA team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12)—a potent immune-boosting protein that holds promise for cancer treatment—loses effectiveness over time when used as an immunotherapeutic. The research challenges long-held assumptions about IL-12's behavior in the body and offers a path toward safer and more effective dosing regimens |
Medical xPress
05 November at 12.15 PM
Scientists identify immune molecule that keeps metabolism in tune and on timeRecent research reveals that the immune system interacts with the body's internal clock, influencing both fat storage and temperature regulation. |
Medical xPress
04 November at 11.51 AM
Berry-flavored vapes may paralyze immune cells in the lungs, study findsBerry-flavored vapes can weaken the lungs' natural defenses, making it harder for the body to fight off infections, research suggests. The study, published in Proceedings of the National Academy of Sciences, compared effects of flavored e-cigarettes to those of unflavored ones. |
Medical xPress
04 November at 11.37 AM
New AI tool identifies better antibody therapiesFrom sending cancer into remission to alleviating COVID-19 symptoms, immunotherapy can provide revolutionary disease treatments. Immunotherapies use antibodies—proteins that bind to cell markers called antigens—to target and eliminate the antigen. But despite how effective immunotherapy can be, it isn't widely used because finding the right antibodies to develop treatments is challenging, time-con |
Medical xPress
31 October at 03.22 PM
First 3D images of complete human thymus illuminate its structure and functionThe first 3D images of a whole human thymus have been created using a specialized X-ray technique by researchers from University College London (UCL) and the Francis Crick Institute. The highly-intricate images showed that structures called Hassall's bodies occupy a large fraction of thymic medulla, suggesting they might play a role in regulating thymic microenvironment and immunity. |
Medical xPress
30 October at 01.44 PM
Immune system review provides insight into more effective biotechnologyMacrophage cells are the immune system's frontline soldiers, early on the scene to protect the body from foreign invaders. These cells answer the immune system's critical question for the rest of its troops: friend or foe? |
Medical xPress
28 October at 02.17 PM
Delayed antibody treatment may improve efficacy of mRNA vaccinesInvestigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and vaccine efficacy in mice, according to a recent study published in The Journal of Clinical Investigation. |
Medical xPress
28 October at 01.53 PM
Imlifidase more effective than plasma exchange in removing donor-specific antibodies in kidney transplant rejectionFor kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)—a procedure that removes antibodies from the plasma portion of the blood. |
Medical xPress
26 October at 04.30 PM
Trial assesses antibody therapy for chronic active antibody-mediated kidney transplant rejectionChronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients' kidney function in a Phase II trial. Investigators now have data from a Phase III trial with clazakizumab. |
Medical xPress
24 October at 11.57 AM
Anaphylaxis treatment remains confusing for patients, caregivers and emergency personnel, research findsAnaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two studies presented at this year's American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston show it is not only patients and caregivers who misunderstand how best to treat anaphylaxis: emergency medical professionals often foll |
Medical xPress
24 October at 10.26 AM
Researchers uncover key to preventing fibrosis in biomaterial implantsA study from the University of Virginia's Department of Biomedical Engineering has identified a critical mechanism driving fibrosis, or scarring, in response to medical implants made with biomaterial hydrogels. |
Medical xPress
24 October at 10.26 AM
Researchers uncover key to preventing fibrosis in biomaterial implantsA study from the University of Virginia's Department of Biomedical Engineering has identified a critical mechanism driving fibrosis, or scarring, in response to medical implants made with biomaterial hydrogels. |
Medical xPress
23 October at 08.00 PM
Mouse study sheds light on the secret to maintaining a youthful immune systemWhat keeps some immune systems youthful and effective in warding off age-related diseases? In a new paper published in Cellular & Molecular Immunology, USC Stem Cell scientist Rong Lu and her collaborators point the finger at a small subset of blood stem cells, which make an outsized contribution to maintaining either a youthful balance or an age-related imbalance of the two main types of immune c |
Medical xPress
22 October at 03.36 PM
Air pollution linked to having a peanut allergy during childhoodExposure to higher levels of air pollution as a baby is linked to having a peanut allergy throughout childhood, according to a new study. And policies aimed at tackling poor air quality could potentially reduce the prevalence and persistence of peanut allergies, it stated. |
Medical xPress
22 October at 11.27 AM
Key receptor reveals how gut cells detect harmful invadersThe human gut is home to helpful microbes, called the microbiota, who produce molecules known as metabolites. These metabolites are being increasingly recognized for their role in supporting our health. |
Medical xPress
21 October at 11.12 AM
Monoclonal antibodies have the potential to treat severe asthma bouts, scientists findScientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for asthma exacerbations than conventional therapies like steroids. |
Medical xPress
17 October at 06.26 AM
Why do I have hay fever? I didn't have it as a childHay fever (or allergic rhinitis) is a long-term inflammatory condition that's incredibly common. It affects about one-quarter of Australians. |
Medical xPress
16 October at 04.16 PM
Exploring the current development and applications of monoclonal antibodiesA study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been published in the journal Molecular Biomedicine. |
Medical xPress
16 October at 03.04 PM
Unique immune response in lupus paves the way for new treatmentsImmune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell Medicine investigators. |
Medical xPress
16 October at 02.36 PM
'Two for the price of one'—scientists discover new process to drive anti-viral immunityScientists at Trinity College Dublin have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to new, effective therapies for people with some autoimmune and infectious diseases. |
Medical xPress
16 October at 12.55 PM
Blood analysis study may help boost performance and reduce side effects of mRNA vaccinesA study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research aimed to help improve the safety and effectiveness of these vaccines, including reducing the side effects that people commonly experience such as headaches, fever and fatigue. |
Medical xPress
16 October at 11.00 AM
Human skin map gives 'recipe' to build skin and could help prevent scarringFor the first time, researchers have created a single cell atlas of prenatal human skin to understand how skin forms, and what goes wrong in disease. |
Medical xPress
15 October at 11.49 AM
Scientists identify key protein in the inflammatory pathway driving fatty liver diseaseScientists at the Agency for Science, Technology and Research (A*STAR) and the Shanghai Institute of Immunology (SII), along with their international collaborators, have dissected the key signaling mechanism driving inflammation in metabolic dysfunction-associated steatohepatitis (MASH), through which they have also uncovered a promising new protein target to combat the fatty liver disease. |
Medical xPress
15 October at 11.37 AM
Researchers show how nutrients and organelle signaling shape tissue immunityThe ability to therapeutically manipulate the immune system presents a multitude of potential opportunities for treating infectious diseases, cancer and other diseases, but first, researchers must fully understand the processes that shape immunity. |
Medical xPress
15 October at 07.10 AM
In depth analysis explains why preschoolers are less likely to develop severe COVID-19Five years ago, at the outset of the coronavirus pandemic, a phenomenon became abundantly clear: Preschool-age children rarely developed severe cases of COVID-19. |
Medical xPress
30 September at 03.20 PM
Immunotherapy for gum disease? Study in mice shows promiseTargeting the immune system could prevent or treat periodontal disease (PD), a common but serious disease of the gums, according to new research from the University of Pittsburgh. |
Medical xPress
30 September at 02.13 PM
Getting the flu and then your flu shot may benefit immunityIn a new study, University of Georgia researchers have found that natural immunity from previous flu infections has a significant impact on how well future influenza vaccinations work. |
Medical xPress
27 September at 01.42 PM
Immune cell analysis helps improve monitoring of rejection risk in kidney transplantsCurrently, kidney transplantation is the most effective treatment to ensure survival and improve the quality of life of patients with end-stage chronic kidney disease, and it is widely practiced in health care systems. However, the monitoring of transplant patients and markers of tolerance to the transplanted organ remain limited. |
Medical xPress
27 September at 01.27 PM
Circadian rhythm disruption linked to lung inflammationIn a study published in the journal Frontiers in Immunology, researchers at the University of Arizona Health Sciences Center for Sleep, Circadian and Neuroscience research have explored the effects of circadian rhythm disruption on the lungs. They have found that nearly every cell in the body is keeping track of time. |
Medical xPress
27 September at 10.57 AM
Research reveals mechanism of effector-triggered immunityA pair of studies examining immune response in C. elegans reveal broad implications for understanding pathogen detection in higher animals and the evolutionary origins of immunity itself. |
Medical xPress
27 September at 12.00 AM
Study finds asthma rates lower in children who received only breast milk at birth hospitalInfants who were exclusively fed breast milk during their hospitalization at birth were 22% less likely to develop asthma in early childhood, according to research presented during the American Academy of Pediatrics 2024 National Conference & Exhibition in Orlando. |
Medical xPress
26 September at 04.05 PM
Nanobodies help decode the central mechanism of inflammationThe formation of pores by a particular protein, gasdermin D, plays a key role in inflammatory reactions. During its activation, an inhibitory part is split off. More than 30 of the remaining protein fragments then combine to form large pores in the cell membrane, which allow the release of inflammatory messengers. |
Medical xPress
26 September at 02.00 PM
Researchers discover new bacterium that causes gut immunodeficiencyCleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut, potentially contributing to certain inflammatory and infectious gut diseases. |
Medical xPress
26 September at 09.42 AM
Novel antibodies against Klebsiella pneumoniae identifiedResearch at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers also managed to unravel how these antibodies interact with antigens on the bacterial surface. Finally, they found that some of these novel antibodies act synergistically to neutralize this p |
Medical xPress
24 September at 04.19 PM
Researchers discover new role of immune cells in eye healthThe eye is an immune-privileged tissue because of the need to keep blood vessels away from the central pathway of light and to restrict entry of inflammatory cells that could cause damage. This has prompted questions about how the eye manages inflammation when it occurs. |
Medical xPress
23 September at 11.41 AM
Study sheds new light on immune dysfunction in children with severe infections and inflammatory diseasesA new study led by King's College London, Imperial College London and the University of Edinburgh, has characterized the similarities and differences between immune cell profiles in children with different infections and inflammatory diseases. |
Medical xPress
20 September at 02.00 PM
Fever drives enhanced activity and mitochondrial damage in a subset of T cells, study findsFever temperatures rev up immune cell metabolism, proliferation and activity, but they also—in a particular subset of T cells—cause mitochondrial stress, DNA damage and cell death, Vanderbilt University Medical Center researchers have discovered. |
Medical xPress
18 September at 10.32 AM
Scientists discover proteins in meat, milk and other foods suppress gut tumorsResearchers led by Hiroshi Ohno at the RIKEN Center for Integrative medical sciences (IMS) in Japan have discovered that food antigens like milk proteins help keep tumors from growing in our guts, specifically the small intestines. Experiments reveal how these proteins trigger the intestinal immune system, allowing it to effectively stop the birth of new tumors. The study was published in the scie |
Medical xPress
17 September at 11.00 AM
Critical immune factor for host defense against MRSA offers potential explanation for unsuccessful vaccine strategiesStaphylococcus aureus, mostly known from its antibiotic-resistant variant methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired infections. According to the most recent data, MRSA killed around 120,000 people in 2022 globally and far more are killed by antibiotic-susceptible strains of S. aureus. |
Medical xPress
16 September at 04.53 PM
Cloning several new anti-interferon antibodies to develop future therapeutic candidatesNew research from The Wistar Institute's Montaner lab—led by Wistar Executive Vice President, director of the HIV Cure and Viral Disease Center, and Herbert Kean, M.D., Family Professor, Luis Montaner, D.V.M., D.Phil.—has successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & researc |
Medical xPress
16 September at 10.07 AM
Monoclonal antibodies offer hope for tackling antimicrobial resistanceMonoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the growing problem of antimicrobial resistance, say scientists. |
Medical xPress
12 September at 01.58 PM
Antibodies in breast milk provide protection against common GI virusA study led by researchers at the University of Rochester Medical Center found that breast milk provides protection against rotavirus, a common gastrointestinal disease that causes diarrhea, vomiting and fever in infants. |
Medical xPress
12 September at 01.55 PM
Indoor allergens worsen respiratory infections in children with asthma, study findsChildren with asthma who are exposed to high levels of indoor allergens, such as cockroach and mouse allergens, are at an increased risk of developing respiratory viral infections with symptoms, according to a new study by researchers at Dell Medical School at The University of Texas at Austin. |
Medical xPress
12 September at 12.41 PM
Using molecular scissors to improve CAR-T cell therapyMayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients. This research by Saad Kenderian, M.B., Ch.B., a consultant in Hematology at Mayo C |
Medical xPress
12 September at 11.02 AM
Gut microbiome found to influence location of immune cellsResearchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité—Universitätsmedizin Berlin (ECRC) have found that different anatomical sections of the gastrointestinal tracts of mice carry different compositions of microbial communities. Moreover, the specific makeup of the microbiota can influence the type and abundance of immune cells in any particular region. |
Medical xPress
11 September at 03.41 PM
Unraveling the role of macrophages in regulating inflammatory lipids during acute kidney injuryAcute kidney injury (AKI) is associated with a poor prognosis, and no effective treatment has been established to date. Understanding the mechanisms that prevent the progression of AKI is crucial. In AKI, immune cells known as macrophages produce lipid mediators (LMs), which are lipids with significant physiological activity that play a pivotal role in promoting and suppressing inflammation. Thus, |
Medical xPress
11 September at 03.13 PM
Cells that die during inflammation send wound-healing messages, study showsA study by the team of Prof. Kodi Ravichandran (VIB-UGent Center for Inflammation Research) and colleagues found that pyroptosis, a form of programmed cell death traditionally thought to be purely inflammatory, also plays a crucial role in promoting healing and tissue repair. This research, published in Nature, opens new avenues for understanding how our bodies respond to injury and could lead to |
Medical xPress
09 September at 10.49 AM
New study reveals specialization of immune cells in different tissuesA new study from Karolinska Institutet has mapped how MAIT cells, which play an important role in the body's defense against microbes, exhibit different properties depending on the tissue they are in. |
Medical xPress
06 September at 12.40 PM
CT-based radiomics nomogram can ID RA-linked interstitial lung diseaseA computed tomography (CT)-based radiomics nomogram model can achieve favorable efficacy for predicting low-risk patients with rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), according to a study published online July 31 in Frontiers in Immunology. |
Medical xPress
06 September at 12.38 PM
Radiology test can be used to diagnose immune checkpoint inhibitor-associated acute kidney injuryImmune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer. However, they can cause a wide variety of autoimmune toxicities, including immune checkpoint inhibitor-associated acute kidney injury (ICI-AKI). |
Medical xPress
04 September at 11.38 AM
Researchers identify mechanism underlying allergic itching, and show it can be blockedWhy do some people feel itchy after a mosquito bite or exposure to an allergen like dust or pollen, while others do not? A new study has pinpointed the reason for these differences, finding the pathway by which immune and nerve cells interact and lead to itching. |
Medical xPress
04 September at 11.00 AM
Sex hormones modulate the immune system to influence disease risk differently, research revealsScientists from the Karolinska Institutet in Sweden and Imperial College London have shown for the first time which aspects of our immune systems are regulated by sex hormones, and the impacts this has on disease risk and health outcomes in males and females. |
Medical xPress
30 August at 11.50 AM
A distinct 'repair' role of regulatory T cells in fracture healingA study in Frontiers of Medicine uncovers a unique reparative function of regulatory T cells (Tregs) in the process of fracture healing, a discovery that adds a new dimension to our understanding of the immune response in tissue regeneration. |
Medical xPress
29 August at 03.14 PM
Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitisA study published in Protein & Cell details experiments conducted to understand the role of IL-24 in atopic dermatitis (AD)-like conditions. |
Medical xPress
28 August at 11.00 AM
Discovery of how blood clots harm brain and body in COVID-19 points to new therapyIn a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks of the disease, while also suppressing the body's ability to clear the virus. |
Medical xPress
27 August at 03.11 PM
Multipurpose vaccine shows new promise in the presence of pre-existing immunityAs researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer "immunologically naive"—in other words, our immune systems are familiar with certain variants of SARS-CoV-2. This familiarity can pose a problem for vaccine development. |
Medical xPress
27 August at 12.32 PM
Researchers identify immune profile for lung disease caused by allergic reactionFibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale's Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature |
Medical xPress
26 August at 11.28 AM
Synthetic immunology: Approaching a turning point in the treatment and prevention of diseaseSynthetic immunology, an innovative field of research that could lead to fundamentally new approaches and methods in the treatment of infectious diseases and cancer, is the topic of a new article published in Nature Nanotechnology. |
Medical xPress
24 August at 02.09 AM
Study identifies metabolic switch essential for generation of memory T cells and anti-tumor immunityA Ludwig Cancer Research study has identified a metabolic switch in the immune system's T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and a T cell subtype found in tumors that drives anti-tumor responses during immunotherapy. |
Medical xPress
22 August at 05.03 PM
Immune cells have a metabolic backup plan for accessing their anti-cancer playbookImmune cells use two different routes to produce acetyl-CoA, an essential metabolite required to fight infection and cancer, reports a study led by Van Andel Institute scientists. |
Medical xPress
22 August at 01.20 PM
T cells can manipulate the memory of innate immune cells, researchers showResearch from Radboud university medical center reveals that T cells from the adaptive immune system can manipulate the memory of innate immune cells. Previously, it was believed that the memory of innate immune cells operated independently. |
Medical xPress
20 August at 12.36 PM
Research pinpoints how early-life antibiotics turn immunity into allergyResearchers at the University of British Columbia have shown for the first time how and why the depletion of microbes in a newborn's gut by antibiotics can lead to lifelong respiratory allergies. |
Medical xPress
20 August at 11.42 AM
T helper cells may be the key to improving annual influenza vaccinesScientists at St. Jude Children's Research Hospital and Washington University School of Medicine have discovered why the flu vaccine can perform poorly. They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza response. |
Medical xPress
20 August at 10.56 AM
New vector vaccine against COVID-19 provides long-term protectionThe protective effect of established COVID-19 vaccines is initially very robust, but wanes relatively quickly. This limitation imposes a need for periodic booster shots, which drives vaccine hesitation. |
Medical xPress
19 August at 01.27 PM
Study shows macrophages form in eye before birth, offering hope for diabetic retinopathy treatmentMacrophages, also known as scavenger cells, are part of our immune system. They destroy invading pathogens and are found in the organs and the bloodstream. Led by Prof. Dr. Peter Wieghofer, professor of cellular neuroanatomy, researchers at the Faculty of Medicine at the University of Augsburg in Germany have now gained new insights into these immune cells in the eye. |
Medical xPress
17 August at 03.32 AM
Rare diseases point to connections between metabolism and immunityInherited diseases of metabolism and immunity have more in common than previously recognized, according to a new study published in the journal Science Immunology. The findings point to a new set of metabolic genes that are important for the function of immune system T cells, and they offer insights that could improve care for patients with these disorders. |
Medical xPress
16 August at 09.42 AM
Structure of a key 'trigger' of immune response solvedAn international collaboration, involving researchers from Monash University and the University of Oxford, has led to a breakthrough in our understanding of how immune responses are started. The study has been published in Nature. |
Medical xPress
15 August at 10.18 AM
Understanding epigenetic control of antibody responsesNorthwestern Medicine investigators have uncovered how antibody responses are regulated by epigenetic factors commonly mutated in cancers, according to a study published in Nature Immunology. |
Medical xPress
14 August at 04.59 PM
New clue into the curious case of our aging immune systemA WEHI study could help solve a long-standing mystery into why a key immune organ in our bodies shrinks and loses its function as we get older. The thymus is an organ essential for good health due to its ability to produce special immune cells that are responsible for fighting infections and cancer. |
Medical xPress
14 August at 11.00 AM
Immune cell regulator discovery could lead to treatments for arthritis and severe COVIDThe discovery of a new regulator affecting immune cells could lead to new treatments to reduce inflammation in diseases including arthritis and severe COVID 19. |
Medical xPress
13 August at 04.24 PM
Could targeting metabolism treat blood clots in antiphospholipid syndrome?Neutrophils are an important type of white blood cell that help your immune system fight infections. One of the many ways neutrophils help is by capturing germs in sticky, spider web-like structures called neutrophil extracellular traps, or NETs. However, excessive formation of NETs is seen in many autoimmune diseases as a sign of exuberant inflammation. |
Medical xPress
09 August at 11.00 AM
Researchers crack a key celiac mystery: Where the gluten reaction beginsPeople with celiac disease must navigate everyday life by avoiding gluten, a protein in wheat, rye and barley which can trigger painful symptoms in the gut, impede the absorption of nutrients and raise the risk of other serious long-term issues. |
Medical xPress
08 August at 02.00 PM
Potential new approach to enhancing stem-cell transplantsA discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body's different blood cells. |
Medical xPress
07 August at 03.12 PM
Researchers develop a new vaccine additive that creates a stronger, tunable immune responseResearchers at Stanford Engineering have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV. In addition to helping vaccine candidates produce stronger, longer-lasting immune responses, the platform will allow researchers to elicit and test different types of immune responses to determine what is most effective for p |
Medical xPress
06 August at 03.04 PM
Recurrent wheezing in children linked to 'silent' viral infectionsNearly a quarter of children with recurrent wheezing have "silent" lung infections that would be better treated with antiviral medications than commonly prescribed steroids that can carry lifelong side effects, new research from the University of Virginia School of Medicine reveals. |
Medical xPress
02 August at 11.00 AM
Scientists discover mast cells trap and use living neutrophils during allergic reactionsKnown for their role in allergic reactions, mast cells have long been recognized as key players in our immune system. When they encounter allergens, they release chemicals that trigger typical allergy symptoms such as tissue swelling and inflammation. |
Medical xPress
31 July at 01.23 PM
Finding immune cells under our very noses: Antibody-producing cells discovered inside the nasal conchaeThe nose is a major gateway to our bodies—for the air we breathe, the aromas we smell and the microbes that make us sick. On its way in, the air passes through nasal conchae, or turbinates—the long, narrow, curled shelves of bone that look like a shell and protrude into the breathing passage. |
Medical xPress
31 July at 11.00 AM
Scientists pioneer new method for measuring immune memory and SARS-CoV-2 response in the nasal passageScientists at La Jolla Institute for Immunology (LJI) have published the first-ever, in-depth analysis of immune cell memory in the upper airways of adult volunteers. Among these immune cells, the researchers spotted "tissue resident" memory cells, which stand ready to defend the airway from SARS-CoV-2 and other respiratory diseases. |
Medical xPress
31 July at 03.25 AM
Australia launches landmark peanut allergy treatment for babiesAustralian children with potentially deadly peanut allergies will be offered life-saving treatment in a nationwide program touted as a world first. |
Medical xPress
30 July at 12.32 PM
Immune cell injections could prevent ischemic leg amputationA study has found that a subset of a special type of white blood cells called monocytes could be the key to regrowing blood vessels in the legs of patients with chronic limb-threatening limb ischemia (CLTI). |
Medical xPress
30 July at 09.46 AM
Route to more effective malaria vaccines revealed through human-challenge trialsInfecting volunteers with malaria reveals why some get sick and others don't—and points to ways to induce stronger immunity through vaccination. |
Medical xPress
26 July at 01.47 PM
Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantationAllogeneic hematopoietic cell transplantation (HCT) is a commonly used curative therapy for individuals with inborn errors of immunity (IEI). HCT involves introducing stem cells from a compatible donor with the aim of replacing the affected cells in the recipient's body. Reduced-toxicity conditioning (RTC) is an approach for reducing drug-related toxicities post HCT in patients with IEIs. |
Medical xPress
25 July at 03.21 PM
T cells and aging: Unraveling the complexities of lifespanAging significantly impacts the immune system, notably through the involution of the thymus, which reduces T cell production. This decline weakens immune responses, making older adults more susceptible to infections and diseases. Aged T cells also exhibit reduced recognition and responsiveness to antigens, impairing immune surveillance and memory. |
Medical xPress
25 July at 09.57 AM
Organoids mimicking celiac disease show new link between gluten and intestinal damageSmall, laboratory-grown balls of cells made from the intestinal tissue of people with celiac disease have revealed a previously unknown molecular link between gluten exposure and intestinal damage, according to a study by researchers at Stanford Medicine. |
Medical xPress
24 July at 12.46 PM
Newly identified immune cell switch could control inflammationCornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help clinicians control inflammation-related conditions such as autoimmune, cardiovascular and neurodegenerative diseases. |
Medical xPress
23 July at 10.10 AM
Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusiveMonoclonal antibodies have become indispensable in medicine to combat cancers, infectious diseases and autoimmune disorders. But the mechanism of action of a major monoclonal antibody developed for ulcerative colitis has remained elusive—until now. |
Medical xPress
22 July at 12.50 PM
Kidney transplantation: Combined cell therapy found to reduce donor-specific immune responseA new combined cell therapy for kidney transplants can help to reduce the donor-specific reaction against the transplanted organ without the need for maintenance triple immunosuppression. The overall diversity of the T-cell receptor repertoire, which is important for immune defense, is preserved. This is shown by an international study led by MedUni Vienna, which was recently published in the jour |
Medical xPress
22 July at 10.20 AM
Researchers turn the body's B cells into tiny surveillance machines, antibody factoriesUSC scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, two of medicine's most formidable foes. |
Medical xPress
19 July at 04.43 PM
Research shows spike gene mutations do not correlate with increased SARS-CoV-2 variant severityNew research from UNC Charlotte's Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) has found that the two recent and prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations |
Medical xPress
19 July at 09.15 AM
New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatmentResearchers from the University of South Australia have developed a new technique to significantly enhance a powerful treatment for leukemia and other blood cancers. |
Medical xPress
18 July at 09.38 AM
Study identifies unpredicted immune responses to adenoviral COVID-19 vaccinesResearchers from the University of Liverpool's Center for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines. |
Medical xPress
18 July at 05.00 AM
Naturally occurring peptide could serve as a novel protective agent for 'inflammaging'A naturally occurring peptide called PEPITEM could potentially rejuvenate the immune response in older individuals and protect against "inflammaging," which is widely believed to be the root cause of many age-related diseases. |
Medical xPress
17 July at 11.40 AM
Immune cells monitor blood platelet maturation in bone marrow, researchers discoverPlatelets play an essential role in wound healing. Underproduction can cause devastating bleeding, while overproduction increases the deadly risk of thromboses. Maintaining a constant level of platelets in the blood (homeostasis) is therefore vitally important. Platelets are continuously formed by megakaryocytes (MKs) and released into the blood. |
Medical xPress
17 July at 10.00 AM
Study shows autoantibodies behind lifelong risk of viral infectionA new study, published in the Journal of Experimental Medicine, shows that about 2% of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID-19. The study, conducted by UZH researchers together with a USZ team, is based on an analysis of a large collection of historical blood samples. |
Medical xPress
16 July at 09.59 AM
Patient-driven discovery reveals potential target for autoimmune diseasesA medical mystery served as the genesis for a Yale-led study that has promising implications for treating a range of autoimmune diseases. |
Medical xPress
15 July at 11.00 AM
Research suggests early life antibiotic increases asthma risk, providing clues to potential prevention of adult asthmaEarly exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University. Importantly, the research team isolated a molecule produced by gut bacteria that in the future could potentially be trialed as a simple treatment, in the form of a dietary supplement, for children at risk of asthma to prevent them developing the disease. |
Medical xPress
12 July at 05.00 AM
Q&A: Researchers discuss cellular inflammation uncovered in rare neurodegenerative conditionResearchers at The Hospital for Sick Children (SickKids) have found that inflammation in an immune cell may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases (LSDs). |
Medical xPress
10 July at 10.51 AM
Immunogenicity of human-induced pluripotent stem cell-derived cardiomyocyte sheetsHuman induced pluripotent stem (hiPS) cells refer to stem cells derived from adult somatic cells like blood or skin cells. hiPS-derived cardiomyocytes (hiPC-CMs) have shown promise in treating ischemic heart disease. However, their clinical application is limited by an incomplete understanding of their immunogenicity. Now, researchers from Juntendo University developed a humanized mice model and e |
Medical xPress
09 July at 01.08 PM
Inulin-gel-based oral immunotherapy may offer long-awaited treatment for food allergy sufferersA study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and purposes. |
Medical xPress
08 July at 04.29 PM
Small molecules induce trained immunity, opening a new approach to fighting diseaseVaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens. |
Medical xPress
08 July at 12.00 PM
Scientists discover how to improve vaccine response to potentially deadly bacteriumResearchers from Trinity College Dublin have taken a leap forward in understanding how we might fight back against the potentially deadly MRSA bacterium. They have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during the delivery of a vaccine improves the ability of the vaccine to protect against infection. |
Medical xPress
08 July at 08.59 AM
New pathway in immune defense discovered: Interaction of monocytes and platelets decodedMonocytes, a special type of white blood cell, secrete cytokines as inflammatory messengers that are crucial for an appropriate immune response. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now discovered that platelets, also known as thrombocytes, communicate with monocytes and increase their inflammatory capacity. |
Medical xPress
08 July at 06.16 AM
Scientists create first mouse model with complete, functional human immune systemA breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. |
Medical xPress
05 July at 01.20 PM
New insights into metabolic and immune pathway interactions in obesityMetabolic and immune pathways are highly regulated and interwoven by multiple mechanisms to govern metabolic health. Dysregulation of these pathways underlies the development of metabolic diseases such as obesity and type 2 diabetes (T2D), which have become prevalent worldwide in recent years. |
Medical xPress
05 July at 09.10 AM
Ointment containing DNA molecules can combat allergic contact dermatitisResearchers at the University of Bonn have isolated a DNA molecule that is suitable for combating allergic contact dermatitis in mice. The aptamer binds to certain immune system messenger substances, rendering them ineffective. This even works if the active ingredient is applied to the skin in the form of an ointment. |
Medical xPress
01 July at 11.36 AM
Protein may hold key to heart transplant toleranceNorthwestern Medicine investigators have uncovered how a protein contributes to heart transplant tolerance in mice, according to a study published in the Proceedings of the National Academy of Sciences. |
Medical xPress
01 July at 10.00 AM
Common respiratory infections may have protected children from COVID-19, study suggestsAnalyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 by boosting their immune systems. Their results are published July 1 in the Journal of Experimental Medicine (JEM). |
Medical xPress
28 June at 11.16 AM
Novel mechanism for targeting bone marrow adipocytes to prevent bone lossBone marrow adipocytes (BMAds) are situated within the bone microenvironment, in close proximity to bone cells, vascular structures, and hematopoietic tissues. The shift of bone marrow stromal/stem cells (BMSCs) lineage towards committed adipogenic progenitors at the expense of osteoprogenitors is driven by abnormal signaling within the bone microenvironment due to pathophysiological conditions. |
Medical xPress
27 June at 03.56 PM
Master autoimmune regulator gets by with a little help from its friendsThe protein Foxp3 is vital to the function of immune cells called regulatory T cells, which control immune system activation. Despite its importance, how Foxp3 regulates the immune system using environmental cues has remained unclear. |
Medical xPress
27 June at 08.00 AM
Two studies show mixed progress against eosinophilic esophagitisDespite high hopes, a drug that wipes out the namesake cell type associated with the disease eosinophilic esophagitis (EoE) doesn't make patients feel better and doesn't reverse tissue damage in their throats. |
Medical xPress
27 June at 07.54 AM
Switching decisions: Interleukin-12 influences B cell immune responseB cells are known to generate antibodies through two different responses—an "emergency response" and an "everything is okay, let's prepare for the future response," says Mark Shlomchik, UPMC Professor and Distinguished Professor of Immunology, University of Pittsburgh School of Medicine. |
Medical xPress
27 June at 06.32 AM
Researchers pioneer production of CAR T-cells using high-density microfluidic bioreactorResearchers have developed a novel method capable of producing clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells in a ultra-small automated closed-system microfluidic chip, roughly the size of a pack of cards. |
Medical xPress
25 June at 12.20 PM
Researchers develop hybrid antibody with improved immune activationAntibodies can be likened to keys, with antigens as the corresponding locks. Each antibody is uniquely shaped to fit a specific antigen, much like a key fits its particular lock. The precise ability to bind to disease-causing proteins makes antibodies invaluable for researchers developing new treatments. |
Medical xPress
25 June at 07.10 AM
Researchers design novel 3D hydrogel culture to study TB infection and treatmentResearchers from the Department of Bioengineering (BE), Indian Institute of Science (IISc), have designed a novel 3D hydrogel culture system that mimics the mammalian lung environment. It provides a powerful platform to track and study how tuberculosis bacteria infect lung cells and test the efficacy of therapeutics used to treat TB. |
Medical xPress
24 June at 02.31 PM
Aerobic exercise tied to improved clinical asthma outcomesModerate- and vigorous-intensity aerobic exercise training are associated with improvements in clinical asthma outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: in Practice. |
Medical xPress
22 June at 03.09 AM
Growth factors linked to stem cell aging in bone marrow studyOur bone marrow—the fatty, jelly-like substance inside our bones—is an unseen powerhouse quietly producing 500 billion new blood cells every day. That process is driven by hematopoietic stem cells that generate all of the various types of blood cells in our bodies and regenerating themselves to keep the entire assembly line of blood production operating smoothly. |
Medical xPress
21 June at 09.29 AM
How a microbe and a prebiotic work together against food allergiesWhat causes food allergies to develop? There's compelling evidence that suggests imbalances of the gut microbiome could be to blame, creating inflammation of the intestinal tract and a gut environment that's prone to food allergies. |
Medical xPress
20 June at 04.51 PM
Engineered enzyme prevents lupus in mice, shows promise for patients with the diseaseAn enzyme-based treatment developed by Yale researchers mitigated autoimmunity and reduced death rates in both genetic and non-genetic mouse lupus models, a new study reveals. |
Medical xPress
20 June at 04.13 PM
CIDP study explores dual-target CAR-T cell therapy for the treatment of relapsed/refractory autoimmune disordersChinese scientists reveal the feasibility, tolerability, and efficacy of BCMA-CD19 bispecific CAR T-cells for treating chronic inflammatory demyelinating polyneuropathy (CIDP) and highlight the potential of CAR-T cell therapy in treating relapsed/refractory autoimmune disorders. This strategy is a promising step toward creating a potentially curable treatment for CIDP. |
Medical xPress
19 June at 01.33 PM
Researchers develop portable serological test for rapid COVID-19 immunity monitoringA team of researchers from the University of California, Los Angeles (UCLA) has developed a new paper-based serological test that can rapidly and accurately monitor changes in immunity against SARS-CoV-2, the virus responsible for COVID-19. This innovative technology promises to revolutionize how we assess and track immunity in individuals, providing critical data to inform public health decisions |
Medical xPress
19 June at 11.40 AM
New research points to 'stem-like' T cells as culprits in ulcerative colitisScientists at La Jolla Institute for Immunology (LJI) have shed light on how an unusual population of T cells may drive harmful inflammation in people with ulcerative colitis, an autoimmune disease that causes damage to the large intestine. |
Medical xPress
18 June at 04.23 PM
Study reviews delivery systems using glycyrrhizic acid for allergen-specific immunotherapyThe prevalence of allergic diseases has been increasing globally, posing significant public health challenges. Allergic reactions can range from mild, such as allergic rhinitis (AR) and conjunctivitis, to severe, like allergic bronchial asthma (BA). Conventional allergy treatments like antihistamines primarily address symptoms rather than underlying immunological mechanisms. |
Medical xPress
18 June at 04.00 PM
Study shows treatment for autoimmune disorder shifts balance of immune cell typesAutoimmune diseases cannot currently be cured, only treated, and this is also true for neuromyelitis optica spectrum disorder, which affects the central nervous system. A Kobe University study of how the treatment acts on the immune system shows that it shifts the balance of types of immune cells. This finding may represent a step toward the development of personalized medicine for autoimmune dise |
Medical xPress
18 June at 01.10 PM
Researchers tie Lebrikizumab to sustained atopic dermatitis treatment effectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago. |
Medical xPress
18 June at 11.00 AM
Discovery of 'new rules of the immune system' could improve treatment of inflammatory diseases, say scientistsScientists at the University of Cambridge have discovered that a type of white blood cell—called a regulatory T cell—exists as a single large population of cells that constantly move throughout the body looking for, and repairing, damaged tissue. |
Medical xPress
18 June at 09.40 AM
Molecular biomarkers for transplant medicine—AI-driven insights predict organ transplant successIn a study published in Nature Medicine, an interdisciplinary team of researchers from The Westmead Institute for Medical Research (WIMR) and the Sydney Precision Data Science Centre at the University of Sydney have, for the first time, identified molecular biomarkers for transplant rejection that are common to all the major transplanted organs: hearts, lungs, livers, and kidneys. |
Medical xPress
14 June at 08.27 AM
Could interferon signature aid in the diagnosis and stratification of pediatric Sjögren's?Due to differences in clinical presentation and limited knowledge, diagnosing Sjögren's disease in children can be challenging. Although dysregulation of multiple immune response pathways has been shown in adults, few studies have investigated pathophysiological mechanisms in children. |
Medical xPress
12 June at 02.42 PM
Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19By late in the pandemic, more than 96% of individuals in the U.S. ages 16 and older had COVID-19 antibodies from infection or vaccination. However, immunity from the virus tends to wane over time. Uptake of the boosters has been quite low, meaning that over time the current high levels of protection will dissipate. |
Medical xPress
12 June at 02.29 PM
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?If you've been sick with COVID-19, you may have some protection against certain versions of the common cold. |
Medical xPress
12 June at 02.18 PM
Putting the brakes on chronic inflammation: Study discovers link between two key pathwaysScientists at Weill Cornell Medicine have discovered a previously unknown link between two key pathways that regulate the immune system in mammals—a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD). This family of disorders severely impacts the health and quality of life of more than 2 million people in the United States. |
Medical xPress
12 June at 11.47 AM
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespanWhile most cell types experience a functional decline after years of proliferation and replication, T cells can proliferate seemingly indefinitely and without detriment. |
Medical xPress
12 June at 11.32 AM
Boosting CAR-T cell therapies from under the skinCAR-T cell therapies are transforming the treatment of previously incurable blood cancers. Six approved CAR-T products have been administered to more than 20,000 people, and more than 500 clinical trials are underway. However, according to a recent study out of the Massachusetts General Hospital, among 100 patients suffering from lymphomas, myelomas or B-cell acute lymphoblastic leukemias that wer |
Medical xPress
12 June at 11.00 AM
Obesity-cancer connection discovery suggests strategies for improving immunotherapyImmune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered. |
Medical xPress
11 June at 05.01 PM
Position paper examines safety of receiving live vaccines while on dupilumabA new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients who are currently being treated with dupilumab, a biologic therapy for various allergic conditions. |
Medical xPress
11 June at 01.38 PM
Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patientsThere is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May 18 in Clinical Gastroenterology and Hepatology. |
Medical xPress
10 June at 04.58 PM
New study helps explain how elderly individuals react differently to COVID-19 than young peopleThe COVID-19 pandemic resulted in over 700 million infections and 7 million deaths worldwide. While age is recognized as a risk factor for severe COVID-19, the reasons for this are not yet fully understood. |
Medical xPress
07 June at 01.43 PM
Study finds primary cilia restrict autoinflammation by mediating PD-L1 expressionCiliopathies are multisystem disorders characterized by the dysfunction of motile and/or non-motile cilia, which show common clinical manifestations of ciliopathies include retinal degeneration, mental retardation, renal abnormality, obesity, and skeletal dysplasia. Fibrosis of vital organs, characterized by the extensive deposition of extracellular matrix components, represents another complicati |
Medical xPress
07 June at 01.03 PM
Patented technology uses curcumin for potent inhibitory effects on the development of food allergyClinton Mathias, associate professor of nutritional sciences in the College of Agriculture, Health and Natural Resources (CAHNR), has discovered a potential new treatment for allergic reactions. |
Medical xPress
07 June at 11.54 AM
Suppressing graft-versus-host disease using immunosuppressive iPS cell-derived regulatory T cellsA recent study by a team led by Professor Shin Kaneko successfully induced regulatory T cell (Treg)-like cells from iPS cell-derived conventional helper T cells (Tconvs) and demonstrated their ability to suppress xenogenic graft-versus-host disease (GvHD). The findings are published in the journal Cell Stem Cell. |
Medical xPress
05 June at 11.00 AM
Scientists determine how cooperative proteins help the immune system identify and attack invadersBacteria, parasites, viruses—the immune system tackles them all. At the front line of the human immune response are cells called macrophages, which are responsible for correctly identifying intruders and then directing how the entire immune system responds. |
Medical xPress
03 June at 09.00 PM
Researchers identify first step in allergic reactions, paving the way for preventative strategiesScientists at Duke-NUS Medical School have identified how the first domino falls after a person encounters an allergen, such as peanuts, shellfish, pollen or dust mites. Their discovery, published in the journal Nature Immunology, could herald the development of drugs to prevent these severe reactions. |
Medical xPress
03 June at 03.56 PM
White blood cell 'nets' could be early warning sign of major immunotherapy complicationA new study from the University of Michigan Health Rogel Cancer Center reveals a connection between the most common type of white blood cells, which act as a first defense in the body's immune system, and a severe complication of CAR T-Cell immunotherapy. |
Medical xPress
03 June at 11.02 AM
New drug shows promise in easing chronic pain, study findsA team of researchers from Virginia Commonwealth University, the University of Texas at Austin and the University of Virginia have made progress toward developing a drug candidate for treating chronic pain more safely. |
Medical xPress
01 June at 06.18 AM
Antibody discovery promises new hope in influenza B battle, paves way for universal vaccineResearchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children, the elderly and other immunocompromised individuals. |
Medical xPress
31 May at 11.20 AM
Researchers don't know why food allergies are so common in Australian childrenAustralia has often been called the "allergy capital of the world". |
Medical xPress
30 May at 11.10 AM
Scientists discover a novel modulator of human regulatory T cellsThe research group of Professor Riitta Lahesmaa have discovered a novel modulator for human regulatory T cells. This novel regulator can strengthen or dampen immune response and provides a new basis for therapeutic approaches for immune mediated diseases. |
Medical xPress
30 May at 11.00 AM
Q&A: Illuminating the mechanisms behind severe inflammation in asthmaJoshua A. Boyce, MD, chief of the Division of Allergy and Clinical Immunology at Brigham and Women's Hospital, is the senior author of a paper published in Immunity, "Mast Cells Control Lung Type 2 Inflammation via Prostaglandin E2-Driven Soluble ST2." |
Medical xPress
28 May at 09.27 AM
Engineered CAR T cells repress signs and symptoms of allergic asthma in mice for a yearA team of molecular oncologists at Tsinghua University's State Key Laboratory of Molecular Oncology, in China, has found that engineered, long-lived and multifunctional T cells repress signs and symptoms of allergic asthma in mice for up to a year. |
Medical xPress
28 May at 09.27 AM
Study demonstrates how cytokines produce long lasting humoral immunity following vaccinationA new study conducted by researchers from the German Rheumatology Research Center Berlin, an institute of the Leibniz Association, and the Charité—Universitätsmedizin Berlin has shed new light on how cytokines, in particular interleukin 21(IL-21), shape long lasting humoral immunity following vaccination. |
Medical xPress
27 May at 09.30 AM
Study finds feeding infants peanut products protects against allergy into adolescenceFeeding children peanuts regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, even after many years when the children ate or avoided peanut as desired. |
Medical xPress
24 May at 12.43 PM
How COVID-19 'breakthrough' infections alter your immune cellsNew research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections. |
Medical xPress
23 May at 02.18 PM
New insights on celery allergies and associated risksCelery, a major cause of vegetable allergies, carries the risk of causing severe allergic reactions, especially in individuals with mugwort pollen sensitization. |
Medical xPress
22 May at 04.55 PM
Study sheds light on the origin of eosinophils and effects of current precision therapiesEosinophils are specialized cells of our immune system. They are identified by their distinctive granules that stain red when treated with an acidic reagent, eosin, that gave them their name. Eosinophils are typically rare in our blood and tissues, accounting for about 3% of our white blood cells. Their biological roles are poorly understood, but recent studies suggest that eosinophils are involve |
Medical xPress
22 May at 03.53 PM
Researchers determine mechanism of action of delta inulin, uncover key to more effective vaccinesResearchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising pathway for advancing the next generation of vaccines. |
Medical xPress
21 May at 03.50 PM
Study reveals how extremely rare immune cells predict how well treatments work for recurrent hivesA study which examines the common skin condition, chronic spontaneous urticaria (CSU), characterized by recurrent hives, has been recently published by Trinity College Dublin researchers in the journal Allergy. |
Medical xPress
20 May at 03.51 PM
Study finds tyrosine kinase Csk promotes germinal center B cell survival and affinity maturationThe immune system strikes a fine balance by identifying and neutralizing disease-causing agents while carefully avoiding destruction of healthy tissues and cells. Now, researchers from Japan have shed new light on one of the processes that helps train immune cells to act only against genuine threats. |
Medical xPress
20 May at 03.02 PM
Research shows linked biological pathways driving skin inflammationA certain biological pathway—a set of linked reactions in the body—drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all inflammatory skin diseases, including atopic and allergic dermatitis and a type of boil called hidradenitis suppurativa, say the study authors. |
Medical xPress
20 May at 11.40 AM
Genetically engineered pig hearts transplanted in two brain-dead patients reveal more about immune responseA large team of biomedical researchers affiliated with a host of institutions across the U.S., the U.K., Saudi Arabia and France, has learned more about many of the factors involved in xenotransplantation as they conducted a large number of tests on two brain-dead human patients that had received genetically engineered pig hearts. |
Medical xPress
18 May at 05.30 PM
Unlocking the body's defenses: Understanding immunotherapyIn the battle against diseases, the human body boasts an intricate defense network capable of identifying and neutralizing threats—the immune system. It serves as a guardian, constantly patrolling the body to keep it safe from invaders like bacteria, viruses, and even cancer cells. |
Medical xPress
18 May at 02.11 AM
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other virusesThe COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of people to the hospital each week and spinning off new variants with depressing regularity. The virus's exceptional ability to change and evade immune defenses has led the World Health Organization (WHO) to recommend annual updates to COVID-19 vaccines. |
Medical xPress
17 May at 11.30 AM
Cell types and molecules usually associated with autoimmune diseases found to be normal components of gut immunityResearchers in the Peter Gorer Department of Immunobiology have identified that features of the immune system that were previously considered to be characteristics of autoimmune diseases are normal components of the immune system in human gut that interact with each other alongside bacteria. The study is published in Nature. |
Medical xPress
17 May at 10.27 AM
Scaffolding sensors detect early evidence of organ transplant rejections in miceA new microporous scaffold functions as a minimally-invasive surveillance method to identify rejection prior to graft injury in a mouse model, according to a study published in Science Advances. |
Medical xPress
16 May at 04.59 PM
Review explores cell-based immunotherapies for sepsisImagine the human body mounting an excessively heightened reaction to an infection, causing multiple organ failures and posing a risk of death. This condition, recognized as sepsis, affects approximately 49 million individuals worldwide annually. To reduce the mortality rate and the global burden of sepsis, the World Health Organization has classified it as a priority research area. |
Medical xPress
15 May at 04.35 PM
Study reveals immunotherapy's potential in boosting immune systems of older individualsPublished in Nature Aging, University of Minnesota Medical School researchers have provided new insight into enhancing immune responses in older individuals and the potential for using immunotherapy to make older adults less vulnerable to infections. |
Medical xPress
14 May at 04.21 PM
Newly identified PET biomarker predicts success of immune checkpoint blockade therapyThe protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment. |
Medical xPress
09 May at 04.49 PM
How antibody levels can predict which children will outgrow their peanut allergyAustralian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy. |
Medical xPress
09 May at 01.44 PM
How ultrasound and microbubbles could deliver immunotherapy to the brainMalignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. Treatments are limited by the blood–brain barrier, a unique structure within the brain formed by tightly connected cells that line the inside of blood vessels. |
Medical xPress
09 May at 11.00 AM
Scientists pinpoint new vaccine adjuvant that promotes potent anti-tumor immunityScientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant called C100 promotes potent anti-tumor immunity when it is injected directly into tumors in an animal model. |
Medical xPress
09 May at 08.53 AM
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areataResearchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including children. |
Medical xPress
08 May at 02.00 PM
Study reveals role of iron in allergic asthma and points to potential new therapiesNew USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs during an allergic asthma attack—and blocking or limiting iron may reduce the severity of symptoms. |
Medical xPress
07 May at 10.34 AM
Gut bacteria metabolite shows promise in fighting inflammatory bowel diseaseGut microbiota or the population of microbial inhabitants in the intestine, plays a key role in digestion and maintenance of overall health. Any disturbance in the gut microbiota can, therefore, have a systemic impact. Intestinal microbes metabolize dietary components into beneficial fatty acids (FAs), supporting metabolism and maintaining host body homeostasis. |
Medical xPress
07 May at 10.14 AM
Key role found for gut epithelial cells in the defense against deadly diarrheal infectionsIntestinal epithelial cells line the inner wall of the gut, creating a barrier against dangerous bacteria like enteropathogenic E. coli that seek to attach to and destroy this barrier. Such pathogens pose significant risks to human health, including infant deaths due to diarrhea, particularly in developing countries. |
Medical xPress
07 May at 09.48 AM
Researchers suggest B-cells may play role in lung transplant rejectionB-cells infiltrating the lungs may be responsible for one of the most common complications in lung transplantation, which can lead to rejection, according to a study published in the Journal of Clinical Investigation. |
Medical xPress
02 May at 11.38 AM
Activation of innate immunity: Important piece of the puzzle identifiedLMU researchers have deciphered the complex interplay of various enzymes around the innate immune receptor toll-like receptor 7 (TLR7), which plays an important role in defending our bodies against viruses. |
Medical xPress
02 May at 10.17 AM
Controlled human infection study paves the way to improving vaccines and therapeutics developmentA first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it. The results suggest that previous infection, together with vaccination, offers strong protection against the original COVID-19 strain. |
Medical xPress
02 May at 09.24 AM
Skin patch improves treatment for pediatric milk allergiesDaily immunotherapy delivered via a dermal patch reduced the risk of reactions, including anaphylaxis, in children with an immunoglobulin E (IgE)–mediated cow's milk allergy, according to a recent clinical trial published in JAMA Pediatrics. |
Medical xPress
02 May at 04.01 AM
Study reveals hidden diversity of innate immune cellsFindings from a new study, led by researchers at Dartmouth's Geisel School of Medicine and published in Nature Immunology, have uncovered key functional differences in macrophages—a type of white blood cell that plays a pivotal role in the body's innate (general) immune system as a first-line defender against pathogens. |
Medical xPress
01 May at 02.00 PM
Experimental vaccine targets portions of the flu virus that don't changeDuke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable. |
Medical xPress
01 May at 10.35 AM
For parents of kids with food allergies, social media can bring support—and stressHaving a child with food allergies isn't easy to manage, and now new research shows that most of these parents turn to social media for medical advice. |
Medical xPress
30 April at 02.28 PM
Gene expression analyses identify potential drivers of chronic allergic inflammationCurrently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, including asthma, atopic dermatitis, ulcerative colitis and more. T helper 2 (Th2) cells play an important role in the body's immune response, particularly in allergic reacti |
Medical xPress
29 April at 02.57 PM
Study reveals interaction mechanism between intestinal microbial environment and tumor immune microenvironmentColorectal cancer stands as one of the leading malignancies in the digestive system, ranking third and second in terms of new cases among men and women worldwide, respectively. Given the high incidence of this disease and the low response rate to immunotherapy, it is imperative to identify the environmental impeding factors to devise more precise and effective therapeutic strategies. |
Medical xPress
29 April at 01.47 PM
Protein responsible for genetic inflammatory disease identifiedA team of researchers led by Dr. Hirotsugu Oda at the University of Cologne's CECAD Cluster of Excellence for Aging Research has discovered the role a specific protein complex plays in certain forms of immune dysregulation. The result may lead to new therapeutic approaches aimed at reducing autoinflammation and "repairing" the immune systems of patients who suffer from a genetic dysfunction of thi |
Medical xPress
29 April at 11.08 AM
Scientists develop new organoid model to study thymus functionResearchers from the Organoid group have developed a new organoid model that can be used to study the thymus. The organoids are derived from mouse thymus tissue, specifically model thymic epithelial cells (TECs). These cells are responsible for training the T cells of the immune system to properly respond to pathogens. |
Medical xPress
26 April at 10.38 AM
How the immune system learns from harmless particlesOur lungs are bombarded by all manner of different particles every single day. While some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The immune system trains its response whenever it encounters such a pathogen. Yet researchers at the University of Bonn have now shown that even harmless particles help to improve the immune response and have published the |
Medical xPress
26 April at 10.26 AM
New research sheds light on the weakening immune response observed in older adultsA fully functioning immune system is essential to help the body maintain good health, and macrophages play a critical role in maintaining robust immune responses against infections. |
Medical xPress
25 April at 11.20 AM
How immune cells communicate to fight viruses: New mouse model enables identification of chemokine producers and sensorsChemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors. To understand this complex network, various techniques have been developed to identify chemokine-producing cells. |
Medical xPress
25 April at 10.30 AM
Identifying a new liver defender: The role of resident macrophagesOsaka University researchers have discovered liver resident macrophages' pivotal role in defending against gut bacteria and related substances entering via the portal vein, particularly under compromised intestinal barrier conditions. Identified as "sentinel macrophages," they are activated by isoallo-lithocholic acid. |
Medical xPress
24 April at 10.56 AM
Scientists team up to expand vaccine science's role in the fight against MRSA and other infectionsDriven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It's estimated that antimicrobial-resistant infections killed more than 1 million people worldwide in 2019, according to the World Health Organization. |
Medical xPress
23 April at 03.57 PM
Swimming short fibrous nasal drops achieve intraventricular administrationAdequate drug delivery across the blood-brain barrier is a critical factor in treating central nervous system (CNS) disorders. Inspired by swimming fish and the microstructure of the nasal cavity, Prof. Cui is the first to develop swimming short fibrous nasal drops that can directly target the nasal mucosa and swim in the nasal cavity, which can effectively deliver drugs to the brain. The paper is |
Medical xPress
22 April at 05.26 PM
Researchers identify connection between air pollutants and allergic diseasesA study by researchers at National Jewish Health published in the Annals of Allergy, Asthma & Immunology reports that air pollutants—including particulate matter, pollen, greenhouse gases, and other harmful substances—can contribute to the development and exacerbation of allergic diseases by disrupting the skin barrier. |
Medical xPress
22 April at 05.11 PM
Bacteria in the intestine that change in response to inflammation could have an impact on our immune systemGut bacteria have emerged as a focal point of scientific exploration, with their intricate roles in our metabolism, nutrition, and overall health coming into sharp focus. New research from the Technion—Israel Institute of Technology has made a discovery that could lead to a better understanding of and treatment for inflammatory bowel diseases (IBD) such as colitis and Crohn's disease. The research |
Medical xPress
19 April at 05.00 AM
Engineered peptides open new avenue for immunotherapy drug developmentIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body. |
Medical xPress
18 April at 03.40 PM
COVID-19 booster immunity lasts much longer than primary series alone, study showsThinking about getting a spring-time booster shot? A new study coming out of York University's Centre for Disease Modelling in the Faculty of Science shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other—sometimes "unintuitive"—revelations of how factors like age, sex and comorbidities do and don't affect immune response. |
Medical xPress
18 April at 01.03 PM
Novel cell therapy treatments offer promise to immune-compromised childrenIn a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care, according to new research published in Nature Communications. |
Medical xPress
18 April at 10.19 AM
Study finds promising biomarker for cellular rejection after organ transplantToday, patients who receive an organ transplant need repeated surgical biopsies to test for acute cellular rejection (ACR) throughout their lifetimes. But a blood test for ACR could be on the horizon following the discovery of a promising biomarker. |
Medical xPress
17 April at 11.03 AM
FDA adds Fasenra indication for severe asthma in childrenThe U.S. Food and Drug Administration has approved an additional indication for AstraZeneca's Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years with severe asthma and an eosinophilic phenotype. |
Medical xPress
17 April at 09.46 AM
Researchers probe immune microenvironment to prevent pediatric liver transplant rejectionChildren with liver transplants must take immunosuppressant medications for life. To maintain tolerance of the transplanted liver, doctors treat transplant rejection and conduct ongoing maintenance immunosuppression by increasing dosages of medication enough to counteract rejection. |
Medical xPress
15 April at 01.40 PM
Planning safe summer camp fun for kids with allergies and asthmaPreparing a kid for summer camp is already a daunting task, and it's even more complicated if your child has allergies or asthma, experts say. |
Medical xPress
12 April at 02.05 PM
Study suggests staying current with COVID-19 vaccinations helps combat emerging variantsNew research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants. |
Medical xPress
12 April at 12.47 PM
New insights on B cells: Researchers explore building better antibodies and curbing autoimmune diseasesFour new studies led by Harvard Medical School researchers at Boston Children's Hospital reveal details about how B cells in the immune system churn out antibodies that become increasingly potent and specific after we're vaccinated or exposed to an infection. |
Medical xPress
10 April at 04.57 PM
Study advances understanding of liver immune response in cirrhosisThe Department of Clinical Medicine at the Miguel Hernández University of Elche (UMH) leads research on the immune system's role in advanced chronic liver disease. Through various experiments on mouse cirrhosis models and human tissues, researchers have examined how the protein LSECtin interacts with the liver's immune response. |
Medical xPress
10 April at 10.00 AM
Respiratory allergies: Newly discovered molecule plays a major role in triggering inflammationThe inflammation process plays a crucial role in allergic respiratory diseases, such as asthma and allergic rhinitis. Although the pulmonary epithelium, the carpet of cells that forms the inner surface of the lungs, is recognized as a major player in the respiratory inflammation that causes these diseases, the underlying mechanisms are still poorly understood. |
Medical xPress
09 April at 09.54 AM
Could CAR-T cell therapy improve kidney transplants?Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match and susceptible to rejection, Mayo Clinic researchers discovered. |
Medical xPress
05 April at 03.00 PM
Study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancerA pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes. |
Medical xPress
04 April at 05.01 PM
Study discovers how chronic lung conditions affect children's immune systemResearchers have made a breakthrough into how two chronic respiratory diseases in childhood affect the immune system, paving the way for better treatments. |
Medical xPress
04 April at 10.40 AM
New study reveals how T cells gain and maintain tolerance to gut bacteriaThe immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease. |
Medical xPress
03 April at 08.32 AM
Hope for treating autoimmune diseases: Researchers explore diagnostic role of the systemic inflammation indexA routine blood test that measures a patient's inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases. |
Medical xPress
01 April at 03.14 PM
Scientists pioneer immunotherapy technique for autoimmune diseasesMayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. |
Medical xPress
31 March at 10.00 AM
Researchers identify new way to inhibit immune cells that drive allergic asthmaResearchers at the Keck School of Medicine, University of Southern California, have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens. The study, to be published in the Journal of Experimental Medicine (JEM), suggests that switching on Piezo1 could represent a new therapeutic approach to reducing lung inflammation and treat |
Medical xPress
29 March at 02.20 PM
An infamous 'inflammasome'—a rogue protein complex—appears to underlie a rare and disabling autoimmune disorderAutoimmune diseases are among the most puzzling because turncoat constituents of the body wage a constant state of war. Sometimes the underlying cause of an autoimmune condition is so obscure—hidden within chemical miscues of the body—that a long investigatory search must be mounted to sleuth out a cause. |
Medical xPress
29 March at 01.42 PM
Researchers discover skin biomarkers in infants that predict early development of food allergiesFood allergies occur often in childhood and can be severe or even fatal. Researchers at National Jewish Health are working to develop a program to prevent food allergies and have now identified early predictors of the condition. |
Medical xPress
26 March at 03.42 PM
Research unveils metabolic strategies to enhance CAR-T cell therapyWhile cancer remains one of the leading global causes of death, advancements in cancer therapies have significantly improved its manageability and potential for cure. Among these revolutionary cancer treatments are chimeric antigen receptor-T (CAR-T) cells, genetically engineered to combat cancer. |
Medical xPress
26 March at 10.48 AM
Researchers find new way to curb asthma attacksA protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says. |
Medical xPress
23 March at 04.40 PM
CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastomaFor patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-specific antigen, in addition to the wild-type EGFR protein, through secretion of a T-cell-engaging antibody molecule (TEAM; CARv3-TEAM-E) results in radiographic tumor regression, according to a study published online M |
Medical xPress
22 March at 01.58 PM
Lymph node-like biomaterial scaffold for augmenting CAR-T cell therapyIn a study published in the journal National Science Review, a research team aimed to enhance treatment efficacy of CAR-T cell therapy for solid tumors. The research was led by Dr. Zhen Gu and Dr. Hongjun Li from the College of Pharmaceutical Sciences at Zhejiang University, along with Dr. Jie Sun from the School of Medicine at Zhejiang University, |
Medical xPress
22 March at 09.00 AM
Study explores characteristics associated with poor COVID-19 antibody responseAdults with certain socio-demographic and clinical characteristics may have weaker antibody responses to COVID-19 vaccination, which could leader to a higher risk of infection, according to a recent study published in Nature Communications. |
Medical xPress
20 March at 11.42 AM
How the body's immune response to bacterial infections could cause detrimental inflammationResearchers co-led by Nanyang Technological University, Singapore (NTU Singapore) and the University of Toulouse, France, have uncovered how bacteria and their toxins prompt the human immune response, leading to inflammation. |
Medical xPress
20 March at 10.15 AM
Bioluminescence technology reveals role of protein in immune response modulationCutting-edge bioluminescence technology pioneered at The University of Western Australia has been used to uncover a potential game-changer in immunotherapy. |
Medical xPress
19 March at 04.46 PM
Examining inflammatory bowel disease after a stem cell transplantA stem cell donation saves a leukemia sufferer's life. Five years later, the patient develops a chronic inflammatory bowel disease that occurs very rarely following a transplant. Researchers from the University of Basel and University Hospital Basel have studied the case and are calling for more extensive genetic analyses in bone marrow donors. |
Medical xPress
19 March at 01.53 PM
Enhanced stability of tristetraprolin found to promote bone health and reduce frailtyA study used a novel transgenic mouse model (TTP knock-in—TTPKI) that has a moderate elevation of TTP systemically to understand if there is a long-term benefit for bone health, thus contributing towards healthy aging. The research was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Cra |
Medical xPress
18 March at 05.06 PM
New study reveals insights into COVID-19 antibody response durabilityResearchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 infection. |
Medical xPress
15 March at 02.00 PM
Researchers discover key metabolic process responsible for rapid immune responsesResearchers from Children's Hospital of Philadelphia (CHOP) identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells. |
Medical xPress
15 March at 01.20 PM
Study uncovers novel mechanisms behind food allergiesA recent Northwestern Medicine study has shed light on the mechanisms of a specific protein that is necessary for the production of IgA antibodies in the gut in response to food allergens, according to findings published in the journal Mucosal Immunology. |
Medical xPress
15 March at 11.49 AM
Exploring why some newborns develop severe infectionsCompared to adults, newborns are highly susceptible to infections and these infections can cause serious health complications and even death. |
Medical xPress
15 March at 11.30 AM
Machine learning classifier accelerates the development of cellular immunotherapiesMaking a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have shown that the laborious first step of identifying tumor-reactive T cell receptors for patients can be replaced with a machine learning classifier that halves this time. |
Medical xPress
14 March at 02.38 PM
Scientists compete to make best predictions about pertussis vaccineScientists love a challenge. Or a friendly competition. Now, scientists at La Jolla Institute for Immunology (LJI) have recently published the results of a competition that put researchers to the test. For the competition, part of the Computational Models of Immunity network, teams of researchers from different institutions offered up their best predictions regarding B. pertussis (whooping cough) |
Medical xPress
14 March at 11.57 AM
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study findsA new study from the Perelman School of Medicine at the University of Pennsylvania shows that antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines. |
Medical xPress
13 March at 02.30 PM
It's in the blood: Donor diets can trigger allergic reactions in blood recipientsAllergic transfusion reactions (ATRs), a potentially life-threatening side effect of blood transfusions with unclear mechanisms, may be linked to food allergies in pediatric patients as per a recent study by scientists from Japan. They found that ATRs may be triggered by the presence of allergens in the donor's blood, influenced by their pre-donation diet. These findings could pave the way for saf |
Medical xPress
13 March at 11.42 AM
New understanding of the gut immune system may hold promise for Crohn's disease patientsTricks played by certain disease-driving gut bacteria might help explain differences in how patients experience Crohn's disease (CD)—a severe and painful chronic inflammatory bowel disease. A new study by researchers from DTU and 3 European universities shows that antibodies in the gut immune system, which line the stomach and intestinal walls and keep harmful bacteria at bay, may be crucial in un |
Medical xPress
12 March at 10.15 AM
Key protein linked to immune disordersA new study has shed light on the importance of the protein STAP-1 in activating certain immune cells. Understanding the role of STAP-1 in these cells could give researchers a better glimpse into immune-related disorders and ways to treat them. |
Medical xPress
10 March at 12.00 PM
Immune cells can adapt to invading pathogens, deciding whether to fight now or prepare for the next battleHow does your immune system decide between fighting invading pathogens now or preparing to fight them in the future? Turns out, it can change its mind. |
Medical xPress
09 March at 10.30 AM
Man vaccinated for COVID 217 times reports no side effects: scientistsA German man who deliberately got vaccinated for COVID-19 a whopping 217 times did not report any side effects from his many jabs, according to researchers studying possibly the "most vaccinated person in history". |
Medical xPress
08 March at 01.13 PM
Study shows good sleep stimulates the immune systemResearchers at LMU Munich have shown that sleep enhances the migratory potential of T cells toward lymph nodes. |
Medical xPress
08 March at 10.52 AM
Optimizing boosters: How COVID mRNA vaccines reshape immune memory after each dosemRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19). These vaccines work by triggering both cellular and humoral immune responses against the spike protein of the virus. |
Medical xPress
08 March at 09.59 AM
Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actionsAntibody therapeutics are a rapidly growing class of drugs used to treat infections as well as a range of diseases. Among them are cancer and autoimmunity particularly important, and the use of antibody therapeutics transforms the lives of patients. Thus, there is an intense interest in engineering new antibody formats with improved efficacy for both therapeutic and prophylactic use. |
Medical xPress
04 March at 03.35 PM
Scientists report positive immune response against mpox using a COVID-19 vaccineScientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, show that a COVID-19 vaccine developed at the organization's Los Angeles campus also protects against mpox, according to research published in Communications Medicine. |
Medical xPress
04 March at 11.04 AM
T follicular helper cells research makes new immune system discoveriesT follicular helper cells (Tfh) are essential for strong antibody-mediated reactions of our immune system during infections and vaccinations. However, if they get out of control, this can cause diseases such as autoimmunity, allergies or cancer. |
Medical xPress
28 February at 05.00 PM
A safer treatment path for high-risk children to overcome food allergiesNew research from the University of British Columbia reveals a safe path to overcoming food allergies for older children and others who can't risk consuming allergens orally to build up their resistance. |
Medical xPress
28 February at 11.50 AM
Eyes serve as immunological barrier in fight against brain pathogens, finds studyThe eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found. |
Medical xPress
28 February at 11.00 AM
The 'switch' that keeps the immune system from attacking the bodyA microscopic battle rages in our bodies, as our cells constantly fend off invaders through our immune system: a complex system of cells and proteins designed to protect us from harmful pathogens. One of its central components is the enzyme cyclic GMP-AMP synthase (cGAS), which acts as a sentinel, detecting foreign DNA and initiating an immune response. |
Medical xPress
28 February at 10.00 AM
How does vaccination thwart pneumococcal infection? Animal model uncovers 'capture and kill' scenarioIn findings that are nothing short of surprising, scientists have demonstrated that the liver is the site where the immune system unleashes its assault on pneumococcal bacteria following vaccination against the potentially lethal pathogens. |
Medical xPress
28 February at 07.21 AM
Review discusses metabolic reprogramming of T cellsWhen foreign antigens trigger an immune response, T cells respond by proliferating and differentiating into two groups—effector and memory cells. Epigenetic and transcriptional pathways mediate this response, but the cells also undergo metabolic reprogramming to meet the dynamic biosynthetic demands of proliferation and differentiation. |
Medical xPress
27 February at 03.57 PM
Researchers identify enzyme key to training cells to fight autoimmune disordersResearchers at the University of Massachusetts Amherst recently released a first-of-its-kind study focusing on the rare autoimmune disorder aplastic anemia to understand how a subset of cells might be trained to correct the overzealous immune response that can lead to fatal autoimmune disorders. The research, published in Frontiers in Immunology, identifies a specific enzyme known as PRMT5, as a k |
Medical xPress
26 February at 02.00 PM
New clinical practice guideline provides evidence-based recommendations for immunotherapy for inhalant allergyThe American Academy of Otolaryngology–Head and Neck Surgery Foundation has published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy in Otolaryngology–Head and Neck Surgery. This clinical practice guideline identifies quality improvement opportunities and provides clinicians trustworthy, evidence-based recommendations on the management of inhalant allergies with immunotherapy, |
Medical xPress
23 February at 02.00 PM
New research shows babies use immune system differently, but efficientlyScientists have long believed that a newborn's immune system was an immature version of an adult's, but new research from Cornell University shows that newborns' T cells—white blood cells that protect from disease—outperform those of adults at fighting off numerous infections. |
Medical xPress
22 February at 10.46 AM
Fighting the flu: The surprising power of a century-old vaccine for tuberculosisAs Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the Research Institute of the McGill University Health Center (RI-MUHC) have discovered a surprising facet about a century-old vaccine for tuberculosis, Bacillus Calmette Guérin (BCG). |
Medical xPress
19 February at 07.43 AM
Spring allergies have wide-ranging effects, say expertsSpring allergies bring to mind thoughts of stuffy noses and watery eyes. But allergies actually affect many different and interconnected systems within a person's body, according to the American College of Allergy, Asthma and Immunology (ACAAI). |
Medical xPress
19 February at 07.41 AM
FDA expands use of asthma med Xolair to treat food allergiesPeople threatened by accidental exposure to foods they're allergic to may have a new weapon of defense: On Feb. 16, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent anaphylactic reactions. |
Medical xPress
14 February at 04.55 PM
Paradigm shift: How a risk-based program is changing health care use and outcomes for children with high-risk asthmaLe Bonheur Children's Hospital's risk-based innovation program Changing High-Risk Asthma in Memphis through Partnership (CHAMP) has significantly decreased health care use related to asthma by targeting barriers to asthma care, according to research published in the Annals of Allergy, Asthma & Immunology. |
Medical xPress
14 February at 01.19 PM
Colostrum provides long-lasting immunity boost for babies, finds studyThe first form of mother's milk a baby receives after birth, known as colostrum, can dramatically alter its susceptibility to worm infections months to years later, according to an international study published in Allergy. |
Medical xPress
14 February at 11.41 AM
Smoking shown to have long-term effects on the immune systemLike other factors such as age, sex, and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. |
Medical xPress
14 February at 11.00 AM
Researchers uncover mechanisms behind enigmatic shapes of neutrophil nucleiNearly 150 years ago, scientists discovered that specialized blood cells serve a vital role in immune system protection against infection and illness. |
Medical xPress
08 February at 05.00 AM
Faulty DNA disposal system found to cause inflammationCells in the human body contain power-generating mitochondria, each with their own mtDNA—a unique set of genetic instructions entirely separate from the cell's nuclear DNA that mitochondria use to create life-giving energy. When mtDNA remains where it belongs (inside of mitochondria), it sustains both mitochondrial and cellular health—but when it goes where it doesn't belong, it can initiate an im |
Medical xPress
07 February at 02.00 PM
Researchers discover new cell that remembers allergiesResearchers with McMaster University and Denmark-based pharmaceutical company ALK-Abello A/S have made a groundbreaking discovery: a new cell that remembers allergies. |
Medical xPress
02 February at 10.49 AM
Research into autoimmune liver condition suggests unique cell movements may drive diseaseResearch suggests that a recent understanding of cell movements may help shed light on the mechanisms driving primary biliary cholangitis (PBC), an autoimmune disease that attacks the bile ducts of the liver. |
Medical xPress
01 February at 01.35 PM
Gut bacteria can process dietary fiber into an anti-allergy weapon, finds new studyThe intricate relationship that exists between humans and the gut microbiome has become a hot research topic, and scientists are constantly uncovering new reasons why a healthy diet can lead to a healthier life. |
Medical xPress
30 January at 01.35 PM
Switching to vegan or ketogenic diet rapidly impacts immune system, study showsResearchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called keto) diet. Scientists closely monitored various biological responses of people sequentially eating vegan and keto diets for two weeks, in random order. |
Medical xPress
30 January at 11.00 AM
Study finds gut microbiota influence severity of respiratory viral infectionThe composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University. |
Medical xPress
30 January at 09.34 AM
Measuring airborne allergen levels to improve allergic respiratory healthNew research shows for the first time that measuring airborne allergen levels could help people with hay fever to better control their symptoms. |
Medical xPress
26 January at 04.24 PM
Common cold or COVID-19? Some T cells are ready to combat bothScientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection. |
Medical xPress
25 January at 10.29 AM
New algorithm may greatly speed up the design of 'humanized' antibodies that workIn the late nineteenth century, physicians started treating human disease with blood serum extracted from immunized horses. But those extracts—which contained antibodies that target disease agents—often produced disastrous immunological response. |
Medical xPress
25 January at 10.03 AM
Researchers establish optimal immunosuppression regimen for pig-to-human kidney transplantsCurrently used Food and Drug Administration-approved transplant drugs—with the addition of an also already FDA-approved complement inhibitor—are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators. The research is published in the Journal of Clinical Investigation. |
Medical xPress
24 January at 03.18 PM
Study in mice uncovers new protective benefit of breast milkAn immune component of breast milk known as the complement system shapes the gut environment of infant mice in ways that make them less susceptible to certain disease-causing bacteria, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. |
Medical xPress
23 January at 04.11 PM
An AI strategy for identifying new immunotherapy targetsResearchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI). This is the first peer-reviewed publication from the two organizations' Discovery Accelerator partnership, designed to advance research in health care and life sciences. |
Medical xPress
23 January at 10.10 AM
Allergy alert: What new guidelines on anaphylaxis could mean for youIf you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis, management and treatment of anaphylaxis. |
Medical xPress
19 January at 02.00 PM
The secret life of CD4+ T cells: From helpers to melanoma fightersA study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has found that CD4+ T cells, traditionally called 'helper T cells' for their role in aiding the activation of other immune cells, are remarkably effective in controlling melanoma. |
Medical xPress
19 January at 02.00 PM
Evolution of the human immune system in the post-omicron eraIt has been four years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging. Despite the extensive immunization programs, breakthrough infections (infection after vaccination) by new variants are common. |
Medical xPress
19 January at 11.00 AM
Researchers create instruction manual to detect rare cells that could unlock secrets to allergiesResearchers with McMaster University have created an instruction manual that will help scientists across the globe find hard to detect B cells. |
Medical xPress
18 January at 04.44 PM
Research uncovers Tle3 protein's role in enhancing memory T cellsThe Xue Lab at the Hackensack Meridian Center for Discovery and Innovation (CDI) has made another breakthrough in better understanding and potentially modulating the immune system to fight diseases. |
Medical xPress
18 January at 03.39 PM
Researchers develop a handheld white blood cell trackerA Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person's white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels. |
Medical xPress
18 January at 02.00 PM
TB: How prior exposure to bacteria changes the lung's innate immune response and what it might mean for vaccinesTuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide—and that number is only growing larger. |
Medical xPress
18 January at 11.23 AM
Prenatal opioid exposure tied to infections, eczema and asthma risk in early childhoodNew research has found that prenatal exposure to prescription opioids, such as oxycodone, methadone and codeine, may impact the development of immune systems. |
Medical xPress
17 January at 04.05 PM
New vaccine design uses immunity against influenza to offer faster protection against emerging pathogensAfter COVID vaccination, it usually takes weeks for our bodies to develop protective antibody responses. Imagine, however, a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19. |
Medical xPress
17 January at 12.32 PM
The anterior chamber of the eye as a servant to medical researchTo mechanistically understand what happens in the living body under physiological and pathological conditions, requires a non-invasive high spatiotemporal resolution research tool. It has been challenging to create such a tool and tremendous time and effort have been committed to solving this difficult task. |
Medical xPress
17 January at 09.37 AM
A new targeted treatment calms the cytokine stormCytokines are chemical messengers that help the body get rid of invading bacteria and viruses, and control inflammation. The body carefully balances cytokines because they help keep the immune system healthy. However, this balance is upset if the immune system overreacts. A serious infection or a severe burn can unleash a cytokine storm in the body. During the storm—also called cytokine release sy |
Medical xPress
16 January at 04.18 PM
Evolutionary conservation of CD4 and LAG-3 and their cytoplasmic tail motifs with opposing immune functionsT cell surface markers CD4 and LAG-3 are related proteins that promote and inhibit cell activity, respectively. However, although LAG-3 has started to gain appreciation as an immune checkpoint molecule that can be targeted in cancer immunotherapy, only CD4 is well understood. |
Medical xPress
16 January at 01.27 PM
For personalized treatment of inflammation, sensitivity to hypoxia must be considered: StudyIf the oxygen level in organs and tissues falls below normal, hypoxia occurs. Then the body launches defensive responses. In many ways, they coincide and overlap with the response to inflammation, because this process is accompanied by local hypoxia. |
Medical xPress
15 January at 11.10 AM
Maturation instead of cell death: Defective signaling pathways disrupt immune cell developmentIn the case of an autoimmune disease, the immune system not only attacks pathogens, but also the body's own cells. Researchers at the University of Freiburg—Medical Center have now been able to show that defective signaling pathways in the body play a decisive role in the development of immune cells, a discovery that opens up new therapeutic approaches for autoimmune diseases such as autoimmune ly |
Medical xPress
12 January at 09.00 AM
How gum disease aggravates chronic obstructive pulmonary diseaseSevere gum disease has been linked to the progression of chronic obstructive pulmonary disease, or COPD, but an understanding of how the connection plays out in the immune system remains unclear. This week in mSystems, a new study identifies immune system cells that play a critical role in the microbial link between COPD and gum disease. |
Medical xPress
11 January at 02.23 PM
Study shows genetically modified pluripotent stem cells may evade immunological rejection after transplantationOne of the biggest barriers to regenerative medicine is immunological rejection by the recipient, a problem researchers at the University of Arizona Health Sciences are one step closer to solving after genetically modifying pluripotent stem cells to evade immune recognition. |
Medical xPress
11 January at 11.15 AM
Commensal T cells: How a healthy microbiome reduces gut inflammationThe microbiome has a profound influence on our health, but exactly how our resident bacteria wield their power is still unclear. A type of T cell appears to provide some answers for gastrointestinal health, a study of the mouse microbiome finds. |
Medical xPress
10 January at 10.25 AM
Nasal spray with antibodies could prevent COVID-19Researchers at Karolinska Institutet have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection. The results imply a new way to protect individuals at high risk from different variants of the SARS-CoV-2 virus and possibly other infections. The study is published in PNAS. |
Medical xPress
09 January at 11.21 AM
Research discovers innate immune cells are more adaptable than previously thoughtNatural killer (NK) cells, part of the innate immune system, can permanently remain in infected tissue and thus contribute to immunological memory, researchers at the University of Würzburg have discovered. |
Medical xPress
09 January at 11.00 AM
Vaccine boosts innate immunity in people with dormant immune cells, finds studyHumans are protected by two branches of the immune system. Innate immunity provides built-in defense against widespread characteristics of bacteria and viruses, while adaptive immunity memorizes individual pathogens that a person has already encountered. Vaccines teach the adaptive immune system about new pathogens without having to go through an actual infection. This has greatly contributed to h |
Medical xPress
08 January at 05.51 PM
Time change for biological aging clocks: How immune cells shape our body's true ageWhen asked, "How old are you?" Most people measure by how many birthdays they've had. But scientists have developed epigenetic clocks to measure how "old" your body really is. At the forefront of aging research, these clocks go beyond our calendar age to try and reveal our biological age—a true marker of how healthy we are. |
Medical xPress
05 January at 01.05 PM
Researchers investigate why vaccines don't work as well in some older adultsAn important aspect to aging is how the immune system changes over time. Such changes have consequences, and they contribute to the greater risk for severe infections and other diseases such as cancer in the aging population. Researchers at The Jackson Laboratory (JAX) and UConn Health are rigorously investigating why vaccines don't work as well in some older adults |
Medical xPress
30 December at 10.20 AM
Updated guidelines released for management of atopic dermatitisIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in the Annals of Allergy, Asthma & Immunology, recommendations are presented for gaining and maintaining control of atopic dermatitis (AD). |
Medical xPress
29 December at 10.00 AM
Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cellsThis study was led by Dr. Shuyang Yu (College of Biological Sciences, China Agricultural University), Dr. Jingyu Xu (The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University) and Dr. Xuguang Du (College of Biological Sciences, China Agricultural University) and illustrated the key role of Mettl3 in CD8 T cell response during acute infection |
Medical xPress
28 December at 07.50 AM
Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell populationOne of the more rigorous debates in immunology has centered on the origin of an enigmatic T cell population that possesses properties imparting memory and stem cell–like qualities, but facts about their genesis were so elusive that debate has raged for nearly two decades about the source of these vital immune system constituents. |
Medical xPress
22 December at 12.30 PM
Researchers discover functional compensatory effects in Treg cellsProfessor Yi Sun's team at the Zhejiang University report a functional compensatory effect between the Ube2m-Rbx1 and Ube2f-Sag axes of the neddylation–Cullin-RING ligases (CRLs) system in Treg cells, using conditional KO mouse models. The team also revealed that both Ube2m-Rbx1 and Ube2f-Sag axes are essentially required for the functions of Treg cells, and elucidated mechanistically that the Rbx |
Medical xPress
22 December at 11.34 AM
New COVID vaccine induces good antibody response to mutated viral variants, finds studyResearchers at Karolinska Institutet and Danderyd Hospital have followed recipients of the new updated COVID-19 vaccine and analyzed the antibody response to different SARS-CoV-2 variants. The results show a surprisingly strong response to the now dominant and highly mutated omicron variants. |
Medical xPress
22 December at 10.40 AM
Polluted air means more asthma attacks for urban kids, says new studyAir pollution may trigger more asthma attacks in urban children and teens, a new study reports. Even moderate levels of ozone and fine airborne particulates—two ingredients of smog—appear to increase kids' risk of asthma attacks, according to findings published online in The Lancet Planetary Health journal. |
Medical xPress
21 December at 02.40 PM
Injected Xolair therapy could prevent food allergies in kidsA new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. |
Medical xPress
21 December at 02.10 PM
Candles, trees, pets: All holiday hazards for kids with asthmaKids are home for the holidays, but the wonders of the season can pose problems for children with asthma. |
Medical xPress
21 December at 11.00 AM
Study reveals new insights on tissue-dependent roles of JAK signaling in inflammationResearchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues. Their findings suggest a more precise approach is required to potentially expand JAK inhibitor use to a wider range of allergy and inflammatory disorders. |
Medical xPress
20 December at 11.14 AM
Novel immunometabolism approach pioneers single-cell spatial metabolomicsAhmet Coskun and his collaborators plan to create a chemical atlas of all the immune cells in the human body, a 3D micromap to help clinicians navigate the complex role of the entire immune system in the presence of different diseases. |
Medical xPress
19 December at 10.10 AM
New web app for COVID-19 immune antibody helps guide vaccine timingWith SARS-COV-2 infection rates rising again, you may be wondering if you should get a COVID-19 vaccine booster shot. Yale physicians have built a tool to help answer these questions. |
Medical xPress
19 December at 04.15 AM
New guidelines released for practitioners treating anaphylaxis and atopic dermatitisTwo new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients. The Joint Task Force is a partnership between the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology. |
Medical xPress
18 December at 04.37 PM
B cell-deficient patients gain protective T cell immunity following SARS-CoV-2 vaccination and infection, study findsB cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers—such as rituximab (RTX)—or from natural immune deficiency. These patients suffer from a weakened immune system that is less effective at combating both viral and bacterial diseases. As B cells are a key type of immune cell that produces antibodies, a defic |
Medical xPress
18 December at 09.34 AM
Researchers develop innovative and flexible method to study immune cell capabilitiesOur body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by pathogens and fight against disease-causing changes in our body, such as the emergence of cancer cells. Cell-mediated cytotoxicity is one of such defense mechanisms carried out by the immune system that fights against foreign cells. |
Medical xPress
16 December at 06.30 AM
Biomedical engineers unveil the dynamics of maternal immune responsesSepideh Dolatshahi, an assistant professor of biomedical engineering at the University of Virginia, is spearheading an exploration of systems immunology in its crucial development phase—during pregnancy. |
Medical xPress
15 December at 02.00 PM
Research shows immune cells shape lung tissue before birth, provides new avenues for treating respiratory diseasesImmune cells play an active and intimate role in directing the growth of human lung tissue during development, researchers find, revolutionizing our understanding of early lung development and the role of immune cells outside of immunity. |
Medical xPress
15 December at 09.43 AM
Exploring the association of Bifidobacterium infantis with T cell immunity in human infantsThe Bacillus Calmette-Guerin vaccine against tuberculosis can elicit a good response in neonates. Infants who are exposed to HIV but are uninfected display an altered immunity to vaccination. |
Medical xPress
14 December at 03.08 PM
Next generation COVID-19 immunization strategies could deliver vaccine directly to the respiratory tractThe global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission. |
Medical xPress
13 December at 05.00 PM
Mpox vaccine triggers equally strong immune response with smaller doses in people with or without HIV, finds studyDelivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows. This also occurred regardless of whether people were living with or without HIV. |
Medical xPress
13 December at 10.58 AM
Could a high-fiber diet improve cancer immunotherapy performance?It's no secret that a high-fiber diet is good for you—just ask Google. Lots of research suggests that eating a high-fiber diet can lower your risk for certain cancers, but less is known about whether fiber can also help you fight a current cancer diagnosis. |
Medical xPress
12 December at 06.30 PM
Patients can interrupt immune-suppressing medicines to boost immunity provided by COVID-19 booster, finds studyA major clinical trial, led by experts at the University of Nottingham, has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine. |
Medical xPress
12 December at 12.10 AM
Scientists find new, better way to develop vaccinesA new paper in Biology Methods & Protocols indicates that researchers in Germany have developed a new system to display epitopes in mammal cells for immunization studies. They believe that this method can help scientists greatly in immunization efforts. |
Medical xPress
11 December at 10.13 AM
Multi-lens array microscope microscope and AI enable faster migration analysis of immune cellsImmune cells fight infectious intruders, for example, or search for incipient cancers. Therefore, they are constantly migrating through the tissues of our body. But in the wrong place, immune cells like neutrophil granulocytes can cause damage. If these white blood cells infiltrate tumors, this is often associated with a poor prognosis for patients. This is why they could benefit from drugs that p |
Medical xPress
08 December at 09.54 AM
Study offers new insights into how immune cells recognize their enemiesIn order for immune cells to do their job, they need to know against whom they should direct their attack. Research teams at the University of Würzburg have identified new details in this process. |
Medical xPress
07 December at 02.05 PM
Researchers discover metabolic pathway specific to granuloma formation in patientsOn good days, the immune system can effectively handle pathogens that invade the body. However, when foreign matter takes the upper hand, the body builds a wall of immune cells called granuloma around the pathogens to isolate them. |
Medical xPress
07 December at 10.41 AM
New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thoughtThe immune system can carry out many biological processes, from killing viruses to fighting cancer, thanks in large part to approximately 100 key cell-signaling proteins called cytokines, which instruct immune cells what to do. Cytokines are also targeted by drugs for many diseases such as rheumatoid arthritis, COVID-19, and cancer, but until now, scientists haven't had a comprehensive view of how |
Medical xPress
06 December at 11.00 AM
Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responsesResearchers have discovered that misreading of therapeutic mRNAs by the cell's decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent 'off-target' immune responses to enable the safer design of future mRNA therapeutics. |
Medical xPress
06 December at 10.15 AM
Researchers show that an influx of water and salts propel immune cells through the bodyResearchers at the Francis Crick Institute, working with Imperial College London, King's College London and University of Cambridge, have shown that an influx of water and ions into immune cells allows them to migrate to where they're needed in the body. |
Medical xPress
04 December at 02.26 PM
Mathematical dermatology: Unraveling the mechanism of urticaria from eruption shapesThe skin is the largest organ in the human body and plays an important role in maintaining homeostasis as well as protecting the body from the outside environment. Skin diseases can be life-threatening or heavily impair patients' quality of life. Urticaria (also called "hives") is common, affecting at least one in five people in their lifetime, and can persist for years or even decades. |
Medical xPress
03 December at 11.00 AM
Research shows that being overweight hampers the body's immune response to SARS-CoV-2University of Queensland-led research shows being overweight can impair the body's antibody response to SARS-CoV-2 infection but not to the protection offered by vaccination. |
Medical xPress
01 December at 06.38 AM
Hope for autoimmune skin disorder sufferers with new immunotherapy strategyBreakthrough research has revealed new ways to remove immune cells that cause skin autoimmune diseases without affecting protective cells that fight infection and cancer. |
Medical xPress
30 November at 03.44 PM
Harnessing the power of a parasite that can stop painFor the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don't hurt. |
Medical xPress
30 November at 10.11 AM
New study uncovers molecular interactions driving multiple inflammasome activation and inflammatory cell deathA team of researchers, affiliated with UNIST have unraveled the molecular mechanisms behind the activation of multiple inflammasomes and their role in inducing inflammatory cell death. This discovery sheds light on the connection between innate immune sensors and provides valuable insights into the functions of inflammasomes in innate immunity and inflammasome biology. |
Medical xPress
29 November at 10.27 AM
Scientists create 'cloaked' donor cell and tissue grafts that escape rejection by the immune systemIn a preclinical breakthrough that could transform cell therapies for incurable diseases, researchers at Sinai Health and the University of Toronto have developed a technology that may one day eliminate the need for immunosuppressive drugs in transplant patients. |
Medical xPress
27 November at 01.09 PM
Scientists devise new technique that can pinpoint causes, treatments of autoimmune diseasesScientists have developed a potentially transformative new technique that could aid in the discovery and development of new therapeutics for a number of globally prevalent autoimmune diseases. |
Medical xPress
27 November at 10.13 AM
Scientists map the antigenic landscapeA new paper in Science Advances details how scientists have succeeded in mapping a central part of the immune system—the HLA class II molecules—while accurately predicting how they display fragments of pathogens on the surface of cells. |
Medical xPress
24 November at 10.43 AM
Fractional COVID-19 booster vaccines produce similar immune response as full doses, study showsReducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full dose with fewer side effects, according to a new study. |
Medical xPress
22 November at 02.17 PM
Anti-rheumatic drugs could prevent thyroid disease, observational study suggestsAnti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine. The paper is titled "Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis." |
Medical xPress
22 November at 12.34 PM
Research reveals pro-phagocytic function and structural basis of GPR84 signalingA recent study, published in Nature Communications, focuses on the interaction between free fatty acids (FFAs) and GPR84, a G protein-coupled receptor (GPCR). |
Medical xPress
22 November at 11.58 AM
Camouflaging stem cell-derived transplants to avoid immune rejectionCell and organ transplants can be lifesaving, but patients often encounter long waiting lists due to the shortage of suitable donors. According to donatelife.net, in 2021, 6,000 people died in the U.S. alone while waiting for a transplant. One day, transplants generated from stem cells may alleviate the constant organ donor shortage, making transplants available to a larger group of patients. |
Medical xPress
21 November at 03.43 PM
Could eating turkey ease colitis? Study suggests extra tryptophan could reduce risk of future flaresThanksgiving is often a time for thinking about your belly. For those with an inflammatory bowel diseases like ulcerative colitis, feasting can be associated with stress, even when food isn't a trigger for the painful symptoms. New research in mice suggests that certain foods—especially those high in tryptophan, like turkey, pork, nuts and seeds—could reduce the risk of a colitis flare. The findin |
Medical xPress
21 November at 01.22 PM
Vitamin B2 derivatives can alleviate chronic kidney inflammation, research suggestsResearchers from the University Medical Center Hamburg-Eppendorf and the University Hospital Bonn have demonstrated that certain derivatives of vitamin B2 can alleviate chronic kidney inflammation in mice. Their findings have been published in the journal Nature Communications. |
Medical xPress
21 November at 11.19 AM
Fixing racial inequities in lupus careReceiving a lupus diagnosis can be a long and frustrating journey. For Black adults, this already difficult process is usually even more drawn out and comes with its own types of challenges. Sadly, racial inequities are a defining feature in the treatment of Black adults with lupus. |
Medical xPress
21 November at 11.03 AM
New discovery furthers understanding of how critical immune cells are controlled during an infectionA recent publication from Audrey Gérard's lab looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection. |
Medical xPress
17 November at 12.48 PM
COVID-19: Vaccination and infection found to trigger differential immune responsesIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scientists from the University Medical Center Göttingen (UMG), in collaboration with the University of Münster, has now investigated this question in the CoV-ADAPT study ("Humoral and cellular immune responses of the adaptive immune system after vaccination or natural COVID |
Medical xPress
16 November at 10.40 AM
Research discovers key molecule that regulates immune memory of natural killer cellsResearchers at the University of Tsukuba have identified a key molecule, Themis2, within natural killer (NK) cells. These cells play a pivotal role in eliminating virus-infected cells. Themis2 remembers viral antigens and further regulates the differentiation of these NK cells into more potent immune memory NK cells, enhancing their killing ability and overall function. |
Medical xPress
15 November at 04.53 PM
STIM-mediated calcium influx regulates maintenance and selection of germinal center B cells: StudyGerminal centers (GCs) are specialized microenvironments where antigen (Ag)-specific B cells undergo antibody affinity maturation and clonal expansion. Positive selection of high-affinity GC B cells is driven by Ag internalization through their B cell receptor (BCR) and presentation to follicular helper T (Tfh) cells. |
Medical xPress
13 November at 04.43 PM
Reviewing new challenges and opportunities for hepatitis B curesHepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading cause of liver disease and death. |
Medical xPress
13 November at 11.56 AM
A high-risk antiphospholipid antibody profile matters in pediatric patients with antiphospholipid syndromeA new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients. The results were presented in a poster session at American College of Rheumatology (ACR) Convergence 2023. |
Medical xPress
13 November at 10.14 AM
Your reaction matters: The role of antibodies in COVID-19 responseEfforts to contain the COVID-19 pandemic have largely focused on vaccine development and deployment. But how exactly do our immune systems respond to COVID-19 vaccines? The major response occurs in one of two ways: the production of antibodies that bind to the receptor-binding domain (RBD) or the production of antibodies that bind to the N-terminal domain (NTD) of the coronavirus viral spike prote |
Medical xPress
10 November at 02.00 PM
A closer look at rebel T cells: MAIT cellsScientists at La Jolla Institute for Immunology (LJI) are investigating a talented type of T cell. |
Medical xPress
09 November at 03.55 PM
Clinical trial data suggests prenatal vitamin D reduces a child's risk of asthmaA review of 15 years' worth of data from the Vitamin D Antenatal Asthma Reduction Trial (VDAART) found that vitamin D supplementation during pregnancy reduced rates of asthma and wheezing in children compared to standard prenatal multivitamin |
Medical xPress
09 November at 11.00 AM
How accurate is ChatGPT at rating common allergy myths? Pretty accurate, says researchArtificial intelligence language models such as ChatGPT are increasingly being used in many different professions, and medicine is not an exception. |
Medical xPress
09 November at 11.00 AM
Survey reveals 42% of primary care physicians are unfamiliar with biologics to treat asthmaBiologics for the treatment of asthma were first introduced about 20 years ago. Since then, more and more people with asthma have found them to be an effective treatment in getting their symptoms under control. |
Medical xPress
09 November at 11.00 AM
Language barriers may cause some children to be underdiagnosed for allergic conditionsAbout 20% of the US population speaks a language other than English when they are at home. The abundance of languages spoken in the United States can pose barriers for some allergy and asthma patients to receive appropriate care. |
Medical xPress
09 November at 11.00 AM
New study examines potential factors related to the development of adult-onset food allergyIt's estimated that 33 million Americans have food allergies (FAs), including 5.6 million children under age 18. The cause of FAs is unknown, although researchers and FA experts have ruled out some common theories of how they develop. |
Medical xPress
09 November at 11.00 AM
Special toothpaste may lower risk of allergic reactions for adults with peanut allergyOral immunotherapy for peanut allergy—introducing small amounts of peanut over a period of time to cause less of a reaction if the person eats something with peanut—has been used by allergists for years to help desensitize those with peanut allergy. |
Medical xPress
09 November at 11.00 AM
Flaxseed allergy appearing more frequently—present in foods and other substancesFlaxseed is an increasingly popular ingredient in baked goods and other food products due to its perceived health benefits. It is even used as a substitute for egg in some recipes. |
Medical xPress
09 November at 11.00 AM
Study shows children with private insurance more likely to outgrow food allergiesSome children will outgrow a food allergy, but how this happens is not well understood. A new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, Calif. shows that children with private insurance are more likely to outgrow food allergies than children who use public insurance. |
Medical xPress
08 November at 04.55 PM
New software tool decodes cytokine 'language' of immune cellsNew research from Yale University has unveiled the complex cellular communication system that allows immune cells to mount responses to infection and cancer. The study, published in Nature Methods, reveals how different cells use cytokines to talk to each other to shape immune responses. |
Medical xPress
08 November at 04.55 PM
A comparative analysis of two SARS-CoV-2 vaccinesThe COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Since then, extensive efforts have been made to develop and evaluate vaccines to combat the virus. One of the promising candidates is GBP510 a recombinant vaccine adjuvanted with AS03, designed to target the SARS-CoV-2 virus's spike receptor-binding domains. |
Medical xPress
06 November at 03.04 PM
Nasal microorganism to the rescue? Study confirms protective role of bacterium in chronic rhinosinusitisLike other countries in the world, Japan has witnessed a worrisome increase in the prevalence of chronic rhinosinusitis (CRS) over the last decade. An inflammatory disease that lasts at least 12 weeks, CRS can cause nasal congestion, nasal discharge, trouble breathing through the nose, facial pain, and even loss of sense of smell. |
Medical xPress
05 November at 01.10 PM
Sublingual immunotherapy safe, effective for treating toddlers' peanut allergyPeanut sublingual immunotherapy (SLIT) is safe and effective at inducing desensitization and remission in 1- to 4-year-old children, according to a study published online Oct. 10 in the Journal of Allergy and Clinical Immunology. |
Medical xPress
03 November at 02.00 PM
Some benefits of exercise stem from the immune system, suggests new studyThe connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race. |
Medical xPress
03 November at 11.11 AM
Scientists identify changes in dendritic cells during the immune response with promising implications for vaccine designA team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital de la Princesa-UAM in Madrid have discovered that dendritic cells, an important cell type in the immune response to viral and bacterial infections, are profoundly changed by their involvement in this process in ways that were previously unknown. |
Medical xPress
02 November at 11.10 AM
Researchers reveal mechanisms of alarmin release at an early stage of immune reactionMany common diseases such as arteriosclerosis and diabetes or neurodegenerative diseases such as Alzheimer's are associated with inflammatory processes. A better understanding of these processes is therefore an important building block for the development of new therapeutic options. |
Medical xPress
31 October at 04.55 PM
Unveiling a novel immune response in the intestinal epitheliumResearchers from the Jan Dobeš laboratory at Charles University in Prague have made a significant discovery uncovering a novel immune response in the intestinal epithelium. Furthermore, their study delineates a mechanism that controls this immune response. |
Medical xPress
30 October at 11.26 AM
Resident T cells discovered in lymph nodesThe immune system is fast when it comes to fighting viruses, bacteria and other pathogens. But it also has to know when not to attack—for example, harmless substances such as pollen or house dust, which otherwise trigger allergic reactions. Regulatory T cells (Tregs) in the lymph nodes play a key role here, suppressing excessive or misdirected immune responses there. |
Medical xPress
30 October at 11.09 AM
Intestinal bacteria metabolite found to promote capture of antigens by dendritic cellsDendritic cells play a key role in the mammalian immune system. These cells are present throughout the human body and are known to capture foreign bodies, or antigens, using extendable "arms" called dendrites. Once captured, dendritic cells present these substances to immune T cells, thereby initiating an immune response. |
Medical xPress
25 October at 11.00 AM
T-cell receptor discovery has huge potential for engineering custom immune responsesT cells are soldiers on the front lines of the human immune system. They are responsible for many important roles, including attacking viral- or bacterial-infected cells and certain cancer cells, and immunological memory—remembering the specific pathogens or the cancer signatures that originally trigger T cells. |
Medical xPress
24 October at 03.41 PM
Newly discovered compound blocks signaling pathway of immune responseScientists at CeMM, the Medical University of Vienna, and the University of Lausanne have succeeded for the first time in identifying and characterizing a new small molecule called "Feeblin," which can inhibit the interaction of the transporter protein SLC15A4 with the adapter protein TASL. Both proteins are part of proinflammatory signaling pathways in the body. In particular, patients with autoi |
Medical xPress
24 October at 11.32 AM
Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasisThe parasitic disease leishmaniasis is found primarily in Central and South America, the Mediterranean region, the Middle East, and Central Asia and is transmitted to humans by a sand fly. An estimated 1.5 million new cases of cutaneous leishmaniasis—the most common form of the disease—occur each year. There is no vaccine, and treatment with anti-parasitic drugs is often unsuccessful. |
Medical xPress
24 October at 10.00 AM
Taking a census of all the immune cells in the human bodyA team of environmental and molecular biologists at the Weizmann Institute of Science, working with a colleague from the Edmond and Lily Safra Children's Hospital and another with The Hebrew University-Hadassah Medical School, all in Israel, has conducted a census of the immune cells that reside in the human body. The group describes their endeavor in a paper published in Proceedings of the Nation |
Medical xPress
24 October at 09.49 AM
New insight into the immune response forges a path toward improved medical implantsIntroducing medical devices—commonly made of materials such as titanium, silicone, or collagen—into our bodies can elicit a host of different immune responses. While some responses can harm our bodies, others can help heal them. Researchers have not fully grasped the rhyme or reason behind the body's reactions, but a new study fills in a critical piece of the puzzle. |
Medical xPress
24 October at 06.02 AM
Uncovering the mysteries of milk allergyCow's milk allergy is the most common type of food allergy in children—it's also the weirdest. |
Medical xPress
23 October at 05.04 PM
Improvements in social, educational and economic-related characteristics of communities may reduce asthmaAsthma is one of the most common, chronic pediatric diseases in the United States, complicated by persistent disparities in care and outcomes. While hospital systems are determined to tackle this issue, researchers believe that the characteristics of a child's neighborhood may be driving inequities in rates of early childhood asthma. |
Medical xPress
20 October at 01.54 PM
Army of specialized T cells may trigger asthma attacks in older menScientists from La Jolla Institute for Immunology (LJI) and The University of Southampton, UK, have uncovered a group of immune cells that may drive severe asthma. These cells, called cytotoxic CD4+ tissue-resident memory T cells, gather in the lungs and appear to possess the molecular weaponry to cause the most harm in men who developed asthma later in life. |
Medical xPress
19 October at 03.09 PM
Novel dynamic imaging technology captures the body's immune response to COVID-19 infectionA team of UC Davis scientists has used dynamic total-body positron emission tomography (PET) to provide the first imaging of the human body's immune response to COVID-19 infection in recovering patients. Their work, published in Science Advances, could lead to a better understanding of how the body's immune system responds to viral infections and develops long-term protection against re-infection. |
Medical xPress
19 October at 11.33 AM
Study sheds light on immune response to COVID breakthrough infectionsWhile COVID-19 breakthrough infections—a SARS-CoV-2 infection that occurs after receiving COVID-19 vaccines—can occur, for healthy individuals with vaccine-induced immunity, these breakthrough infections do not often cause severe disease. There has been limited research to uncover why these breakthrough infections do not lead to severe infections, until now. |
Medical xPress
18 October at 04.08 PM
Immunogenicity and safety of an E. coli-produced human papillomavirus vaccine: A phase 2 controlled trialPremalignant and malignant lesions of the cervix and other sites related to the human papillomavirus (HPV) infection pose a significant health burden worldwide, especially in developing countries. Although prophylactic HPV vaccination is considered one of the most effective measures to prevent cervical cancer and other related diseases, accessibility to HPV vaccines, particularly the 9-valent HPV |
Medical xPress
18 October at 03.41 PM
Study: Older kidney transplant patients metabolize immunosuppressive drugs slower than younger peopleAt one time, individuals over age 65 typically did not qualify for a kidney transplant. Now, due to advances in medicine and longer life expectancies, these patients represent approximately 15% of all kidney transplants, according to researchers at the University at Buffalo. Meanwhile, transplants that were performed in younger patients decades ago last longer, and these recipients are now aging. |
Medical xPress
16 October at 01.00 PM
Ragweed, mold and more: Get ready for fall allergiesWhile the hot, dry summer may have offered a break to people with some environmental allergies, that reprieve could be over. |
Medical xPress
16 October at 10.00 AM
New research points out ways to improve tuberculosis vaccinesA new study from the University of Pittsburgh Center for Vaccine Research published in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection. |
Medical xPress
15 October at 12.40 PM
Study reveals how young children's immune systems tame SARS-CoV-2New research helps explain why young children have lower rates of severe COVID-19 than adults. A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood. This immune response contrasts with that typically seen in adults with SARS-CoV-2 infection. The rese |
Medical xPress
13 October at 02.00 PM
Could the nerve cells that scratch be the solution for itch?It can be a relief to scratch the occasional itch, but when itch gets out of control, it can become a serious health problem. How does the body know when to stop? |
Medical xPress
11 October at 04.43 PM
COVID-19 vaccination: How the body builds immune memory in organsOne shot in the arm, and the whole body is protected. But how? For one thing, the immune system produces antibodies and cells that patrol the entire organism by traveling through the bloodstream. For another, as shown by a recent Charité—Universitätsmedizin Berlin study of the mRNA coronavirus vaccines, the body builds local immune memory in various organs. |
Medical xPress
11 October at 04.01 PM
Study uncovers how the gut's microbiome boosts immune developmentA study is shedding new light on how the gut's microbial communities contribute to a well-functioning immune system and defend against harmful pathogens. |
Medical xPress
11 October at 03.55 PM
The intricate mechanism behind the immune system's ability to differentiate between self and non-self antigensA new study, led by Professor Kyemyung Park and his research team in the Graduate School of Health Science and Technology and the Department of Biomedical Engineering at UNIST has shed light on the intricate mechanism behind the immune system's ability to differentiate between self and non-self antigens. Their research, published in Trends in Immunology, presents a novel quantitative framework tha |
Medical xPress
11 October at 02.37 PM
Examining immune system disorders in women with silicone breast implantsScientists from the St Petersburg University Laboratory of the Mosaic of Autoimmunity have conducted a comprehensive examination of women who have undergone silicone augmentation mammoplasty. The doctors have found a slight increase in the level of autoantibodies against the hormone receptor that controls the functioning of the thyroid gland. |
Medical xPress
11 October at 02.00 PM
Your immune system makes its own antiviral drug—and it's likely one of the most ancientAntiviral drugs are generally considered to be a 20th century invention. But recent research has uncovered an unexpected facet to your immune system: It can synthesize its own antiviral molecules in response to viral infections. |
Medical xPress
11 October at 02.00 PM
Trial results indicate potential for organ transplantation without long-term immunosuppressionGiving living donor liver transplant recipients an infusion of immune cells derived from their donor a week before transplantation is feasible, safe—and may lead to recipients being successfully weaned off immunosuppressant medications without rejecting the transplanted organ. |
Medical xPress
10 October at 01.49 PM
B cell response after influenza vaccine in young and older adultsA new research paper was published in Aging, titled "High-throughput single-cell profiling of B cell responses following inactivated influenza vaccination in young and older adults." |
Medical xPress
06 October at 06.38 AM
Engineered platelets can induce anti-inflammatory, immunosuppressive response, finds scientistNew research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune responses. The discovery, published in the journal Research, constitutes a fundamental re-understanding of platelets and could lead to potential therapies to treat autoimmune and alloimmune diseases, says Dr. Heyu Ni, a scientist at the Keenan Research Center for Biomedical Sciences. |
Medical xPress
05 October at 02.00 PM
Vulnerability to different COVID-19 mutations depends on previous infections and vaccination, study suggestsA person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure—and differences in the focus of immune responses will help scientists understand how to optimize vaccines in the future to provide broad protection. |
Medical xPress
05 October at 01.20 PM
Fungal toxin triggers traps: Revealing the clever defense of white blood cellsResearchers from Umeå University have unveiled how the most common white blood cells, neutrophils, counter Candida albicanstoxin and stop it in its tracks. Their results have been published in EMBO Reports. |
Medical xPress
04 October at 02.00 PM
Hospital superbugs: Could one vaccine rule them all?What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings? |
Medical xPress
04 October at 12.48 PM
Cell death: Immunologist explains when cells decide to die with a bang or take their quiet leaveLiving cells work better than dying cells, right? However, this is not always the case: your cells often sacrifice themselves to keep you healthy. The unsung hero of life is death. |
Medical xPress
03 October at 03.57 PM
From A to Z: An alternative base modification for mRNA therapeuticsMessenger RNA (mRNA) technology has become popular in the last few years due to its use in COVID-19 vaccines. This technology has been so groundbreaking that it recently won the 2023 Nobel Prize in medicine "for discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19." |
Medical xPress
03 October at 02.22 PM
Infant immune systems found to have unique and effective responses to SARS-CoV-2Research led by the University of Tübingen, Germany, along with partners at Stanford University, Emory University and the Cincinnati Children's Hospital Medical Center, U.S., has looked into infant immune responses following SARS-CoV-2 infections during the initial months of life. |
Medical xPress
03 October at 11.25 AM
Nobel prize in medicine awarded to mRNA pioneers. How their discovery was integral to COVID vaccine developmentBillions of people around the world have received the Pfizer or Moderna COVID-19 vaccines. The rapid development of these vaccines changed the course of the pandemic, providing protection against the SARS-CoV-2 virus. |
Medical xPress
03 October at 11.00 AM
Can science take the STING out of runaway inflammation?Until the COVID-19 pandemic exploded, few people outside of research labs and intensive care units had heard of a cytokine storm. But once this dangerous form of infection-triggered runaway inflammation started claiming lives by the thousands, a legion of scientists jumped into the hunt for ways to calm these storms. |
Medical xPress
30 September at 10.10 AM
Making immunotherapy safe for AMLAcute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal antibodies or CAR T-cell therapy are effective for certain blood cancers, they have not been possible in AML because of toxicity concerns. It's been hard to find targets on le |
Medical xPress
29 September at 02.00 PM
Allergy study on 'dirty' mice challenges the hygiene hypothesisThe notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis. |
Medical xPress
29 September at 10.57 AM
Interleukin-22 study provides better understanding of immune responses in inflammatory bowel and lung diseaseAn immune factor released by white blood cells during infection or inflammation works to suppress the body's immune response instead of enhancing it, according to Mater researchers. |
Medical xPress
29 September at 10.00 AM
Study identifies new pathway to suppressing autoimmunityResearchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body's own, healthy tissues. |
Medical xPress
26 September at 09.06 AM
Yeasts as triggers of altered immune responses in inflammatory bowel diseaseChronic bowel inflammation is based on an excessive or misdirected inflammatory reaction. Experts assume that the immune system also reacts incorrectly to microorganisms in the intestine that do not cause an inflammatory immune reaction in a healthy state. But which microorganisms trigger this immune response and how exactly the immune cells react is still largely unknown. |
Medical xPress
25 September at 03.30 PM
Medical researchers tackle immune rejection of biomedical implantsTo learn more about what causes the body to reject biomedical implants, a team at the University of Arizona College of Medicine-Tucson identified a protein that appears to help drive this response, and hopes their discoveries will improve the design and safety of biomedical implants. The findings were published today in Nature Biomedical Engineering. |
Medical xPress
25 September at 11.00 AM
People with long COVID have distinct hormonal and immune differences to those without the conditionLong COVID patients have clear differences in immune and hormone function to patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine. |
Medical xPress
22 September at 12.00 PM
New research adds evidence to the benefits of ginger supplements for treating autoimmune diseasesNew research has revealed a potentially important role ginger supplements can play in controlling inflammation for people living with autoimmune diseases. |
Medical xPress
22 September at 11.58 AM
High systemic immune-inflammation index tied to higher mortality with peritoneal dialysisAn elevated systemic immune-inflammation index (SII) is independently associated with increased risks for all-cause and cardiovascular-specific mortality in patients undergoing peritoneal dialysis, according to a study published online Aug. 31 in the Journal of Inflammation Research. |
Medical xPress
21 September at 02.16 PM
Study details immune cells vital to success of vaccines against coronavirusA study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2. |
Medical xPress
20 September at 03.07 PM
Single-cell RNA-sequencing analysis reveals immune cell heterogeneity in five autoimmune diseasesAutoimmune diseases are a group of diseases caused by abnormal immune attacks on healthy cells, tissues or organs. Single-cell RNA-sequencing (scRNA-seq) technology provides transcriptomic information at the single-cell resolution, thus offering a new way to study autoimmune diseases. Most single-cell RNA-seq studies, however, have often focused on one type of autoimmune disease. |
Medical xPress
20 September at 11.00 AM
Reducing stress on T cells makes them better cancer fightersEven for killer T cells—specialized immune cells—seeking and destroying cancer cells around the clock can be exhausting. If scientists can understand why killer T cells become exhausted, then they can create more resilient cancer-killing cells. |
Medical xPress
19 September at 02.00 PM
Training the gut's immune system to combat detrimental effects of emulsifiers in processed foodIn a new study, mice whose immune systems were trained against the microbial protein flagellin did not experience the usual detrimental effects of ingesting food additive emulsifiers, pointing to a potential new way to combat various chronic inflammatory diseases. Melissa Kordahi and Benoit Chassaing, Inserm researchers from the Institut Cochin and Université Paris Cité, France, and colleagues pre |
Medical xPress
19 September at 09.00 AM
Treating non-alcoholic steatohepatitis by removing cholesterol from macrophages using a unique supramoleculeA research group from the Graduate School of Medicine and Research Institute of Environmental Medicine at Nagoya University report that cholesterol accumulation in macrophages promotes liver fibrosis in the development of non-alcoholic steatohepatitis (NASH). |
Medical xPress
14 September at 05.22 PM
Lego-like gene editing tool lets researchers improve cancer immunotherapyIn recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics that can attack cancers. But such immunotherapies don't work for all patients or all cancer types, and screening through every possible combination of genetic changes that might improve these reprogrammed immune cells is a daunting and slow task. |
Medical xPress
14 September at 02.00 PM
Study pinpoints specialized gut immune cells that can limit progression of inflammatory bowel diseaseResearchers at the Francis Crick Institute, King's College London and Guy's and St Thomas' NHS Foundation Trust have characterized a specialized type of immune cell, which plays a key role in protecting and repairing the cells in the healthy human gut. |
Medical xPress
14 September at 11.18 AM
Study shows mixing donor and recipient immune systems creates tolerance of transplanted kidneysSuccessful kidney transplants rely on the biological compatibility of the donor and recipient but still require long-term use of drugs to tamp down the recipient's immune system and prevent donor organ rejection. Finding a method to increase compatibility can help recipients tolerate a life-saving organ transplant without the lifelong need for anti-rejection medications. |
Medical xPress
11 September at 05.27 PM
'Inverse vaccine' shows potential to treat multiple sclerosis and other autoimmune diseasesA new type of vaccine developed by researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis, type 1 diabetes, and Crohn's disease—all without shutting down the rest of the immune system. |
Medical xPress
11 September at 04.41 PM
Leading asthma groups tackle definition of clinical remission in treatment of asthmaAs an increasing number of improved asthma treatments are developed, a greater number of people with asthma are finding their symptoms under control. Their improved status raises an important question for health care providers (HCPs) who treat this condition: "What qualifies as clinical remission in the treatment of asthma?" |
Medical xPress
11 September at 03.50 PM
Research highlights novel approach to diminish soy allergen immunoreactivitySoybeans, a major source of protein for millions globally, is one of the leading foods causing allergies. According to the World Health Organization, there are eight allergenic fractions in soybeans, with β-conglycinin and glycinin being the major concern. |
Medical xPress
08 September at 09.23 AM
Study shows microRNAs in immune cells help protect against metabolic defects in obesityVanderbilt researchers have demonstrated that a cluster of microRNAs—small pieces of RNA that regulate gene expression—work in a type of immune cells called macrophages to help protect against metabolic defects in obesity. |
Medical xPress
07 September at 02.00 PM
Chitin from crustaceans, insects, mushrooms engages the immune system during digestionWho can forget the stomach-churning moments when "Survivor" contestants forced down crunchy insects, among other unappetizing edibles, for a chance to win $1 million? In daring culinary challenges, the TV show's contestants exhibited gastronomic bravery as viewers watched in discomfort. |
Medical xPress
06 September at 03.13 PM
Study identifies cause of rapid loss of vaccination protection in autoimmune diseasesPeople who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn's disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average. The mechanism underlying the early decrease in antibody levels has now been elucidated by a scientific team from MedUni Vienna. |
Medical xPress
01 September at 02.00 PM
Immune cells shape their own path: Scientists show how immune cells migrate along self-generated gradientsWhen fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) have now discovered that immune cells actively generate their own guidance system to navigate through complex environments. This challenges earlier notions about these movements. |
Medical xPress
31 August at 04.14 PM
New method uses optics and AI to find viruses fasterResearchers have developed an automated version of the viral plaque assay, the gold-standard method for detecting and quantifying viruses. The new method uses time-lapse holographic imaging and deep learning to greatly reduce detection time and eliminate staining and manual counting. This advance could help streamline the development of new vaccines and antiviral drugs. |
Medical xPress
31 August at 11.09 AM
Q&A: Expert discusses the 'boundless potential' of CAR T cell therapyFor most of modern medicine, cancer drugs have been developed the same way: by designing molecules to treat diseased cells. With the advent of immunotherapy, that changed. For the first time, scientists engineered patients' own immune systems to recognize and attack diseased cells. |
Medical xPress
30 August at 02.08 PM
Plant-based diet may be useful in treating allergic diseases associated with obesityAllergic diseases are a group of chronic inflammatory disorders of the lung, skin and nasal epithelium characterized by aberrant IgE and Th2 cytokine-mediated immune responses to exposed allergens. A wide range of nutrients and dietary components have been shown to play critical roles in the prevention or treatment of allergic diseases through host and gut microbiota-derived metabolites. |
Medical xPress
29 August at 11.24 AM
Researchers uncover early signs in gut bacteria that could predict peanut allergy developmentA new study led by researchers at the Icahn School of Medicine at Mount Sinai has revealed key differences in gut bacteria and their metabolic byproducts in infants that may predict the development of peanut allergies by mid-childhood. The findings, published online August 22 in the Journal of Allergy and Clinical Immunology, could pave the way for new strategies to prevent or treat this increasin |
Medical xPress
29 August at 07.30 AM
Turncoat T cells underlie assault on small intestine amid gluten-induced chaos of celiac diseaseWheat, barley and rye contain a protein that can produce severe intestinal symptoms in people with celiac disease, and a team of scientists at Columbia University in New York has now identified distinct signatures of immune system cells that drive the disorder. |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
HealthDay
23 October at 10.58 PM
Risk for Psychiatric Disorders Up for Offspring of Moms With Eating DisorderOffspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula |